ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Research Article

The developmental transcriptome of contrasting Arctic charr (Salvelinus alpinus) morphs

[version 1; peer review: 2 approved with reservations]
PUBLISHED 01 Jun 2015
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

Abstract

Species and populations with parallel evolution of specific traits can help illuminate how predictable adaptations and divergence are at the molecular and developmental level. Following the last glacial period, dwarfism and specialized bottom feeding morphology evolved rapidly in several landlocked Arctic charr Salvelinus alpinus populations in Iceland.  
To study the genetic divergence between small benthic morphs and limnetic morphs, we conducted RNA-sequencing charr embryos at four stages in early development. We studied two stocks with contrasting morphologies: the small benthic (SB) charr from Lake Thingvallavatn and Holar aquaculture (AC) charr.
The data reveal significant differences in expression of several biological pathways during charr development. There was also an expression difference between SB- and AC-charr in genes involved in energy metabolism and blood coagulation genes. We confirmed differing expression of five genes in whole embryos with qPCR, including lysozyme and natterin-like which was previously identified as a fish-toxin of a lectin family that may be a putative immunopeptide. We also verified differential expression of 7 genes in the developing head that associated consistently with benthic v.s.limnetic morphology (studied in 4 morphs). Comparison of single nucleotide polymorphism (SNP) frequencies reveals extensive genetic differentiation between the SB and AC-charr (~1300 with more than 50% frequency difference). Curiously, three derived alleles in the otherwise conserved 12s and 16s mitochondrial ribosomal RNA genes are found in benthic charr.

The data implicate multiple genes and molecular pathways in divergence of small benthic charr and/or the response of aquaculture charr to domestication. Functional, genetic and population genetic studies on more freshwater and anadromous populations are needed to confirm the specific loci and mutations relating to specific ecological traits in Arctic charr.

Keywords

Salmonids, Aquaculture, ecomorphs, Polymorphism, parallel evolution, immunology, craniofacial divergence, mtDNA

Introduction

Historical contingencies and chance shape organisms during evolution1,2, but convergence in phenotype and molecular systems indicates that evolution is to some extent predictable3,4. Identification of genes and variants that influence evolved differences is not a trivial task5. Ideal systems to study the role of chance and necessity in ecological evolution would be related species or populations with readily observable phenotypic variation, living in a tractable ecological setting, and most crucially showing parallel evolution of specific traits within/among species/populations. Examples of such a species complex are the finches of the Galapagos islands, cichlids in the African great lakes are exciting multi-species systems in this respect6,7. The threespine stickleback has also emerged as a model “single species” system8. The amount of diversity in the feeding specializations of fish provide great opportunities for studying adaptation and divergence at the developmental and genetic level.

Transcriptomic methods have been to address evolutionary and ecological questions in fish. For example microarrays were used to compare gene expression in anadromous and resident populations of brown trout (Salmo trutta), revealing that life history was a better predictor of gene expression in the liver than relatedness9. The newer technique, RNA-sequencing (RNA-seq) has been applied to species such as the Mexican cavefish (Astyanax mexicanus), cod (Gadus morhua) brook charr (Salvelinus fontinalis) and Atlantic salmon (Salmo salar)1015, addressing questions concerning evolution, molecular genetics, development and aquaculture. RNA-seq was used to study salinity tolerance in Arctic charr, linking expression and quantitative trait loci16. Microarray studies of adult lake whitefish (Coregonus clupeaformis) pointed to parallel expression differences between benthic and limnetic forms17. Filteau et al. (2013)18 found that a set of coexpressed genes differentiated the two whitefish morphotypes, implicating Bone morphogenesis protein (BMP) signaling in the development of ecological differences in tropic morphology. One approach to identify pathways related to function or morphological differences is to study gene expression during development19,20.

Some northern freshwater fish species exhibit frequent parallelism in trophic structures and life history and in several cases are they found as distinct resource morphs8,2125. One of these species, Arctic charr (Salvelinus alpinus), is well suited for studying the developmental underpinnings of trophic divergence and parallel evolution. Local adaptation has been extensively studied in the salmonid family, to which Arctic charr belongs26. The family is estimated to be between 63.2 and 58.1 million years old27,28. A whole genome duplication event occurred before the radiation of the salmonid family2932 which has provided time for divergence of ohnologous genes (paralogous genes originated by whole genome duplication event). Furthermore, recent estimates from the rainbow trout (Oncorhynchus mykiss) genome suggest that ohnologous genes were lost at a rate of about 170 ohnologous genes per million years and by utilizing multiple data sources the genome assembly problem of this family can be solved32. De novo assembly of genomes and transcriptomes is complicated if many paralogs are present, such as in salmonids. Furthermore, for data with short reads, mapping to a related reference genome/transcriptome is recommended over de novo assembly33.

Molecular studies of the highly polymorphic Arctic charr

Following the end of the last glacial period, about 10.000 years ago, Arctic charr colonized northern freshwater systems34. It can be found as anadromous or lake/stream residents and exhibits high level of within species polymorphism23,34. Resource polymorphism in charr correlates with ecological attributes3537. For instance small charr with benthic morphology, are found in multiple lavaspring and pond habitats in Iceland38, and a comparative study of Icelandic lakes37 found that lakes with greater limnetic habitat, fewer nutrients, and greater potential for zooplankton consumption appeared to promote resource polymorphism. Some of the larger lakes contain two or more distinct morphs, typically limnetic and benthic forms. Multiple lines of evidence show that these differences stem both from environmental and genetic causes3943. The best studied example of sympatric charr are the four morphs in Lake Thingvallavatn44; two have a benthic morphotype, a large benthivorous (LB-charr) and a small benthivorous (SB-charr), and two morphs are limnetic, a large piscivorous morph (PI-charr) and small planktivorous morph (PL-charr)45. Both PL and PI-charr operate in open water and feed on free-swimming prey, PL on planktonic crustaceans and PI on small fish.

Several population genetics studies, using allozymes and mtDNA revealed no differences among charr populations4648, while studies on microsatellite markers and nuclear genes, reveled both subtle4951 and strong genetic differences among morphs52. Importantly Kapralova et al. (2011)51 concluded that small benthic morphs have evolved repeatedly in Iceland and that gene flow has been reduced between the PL and SB morphs in Lake Thingvallavatn since its formation approximately 10,000 years ago53. We also discovered genetic separation in immunological genes (MHCIIα and cath2) between morphs in Iceland and within the lake52, consistent with ecologically driven evolution of immune functions. Recently qPCR analyses showed that expression of mTOR pathway components in skeletal muscle correlates with the SB-charr form in Iceland54, but it is unknown whether there is genetic differentiation in those genes or upstream regulators.

Because individual genes have distinct histories55,56, genome wide methods are needed to identify genes and mutation that associate with divergence. Icelandic aquaculture charr (AC) was founded with fish from the north of Iceland, and has been bred at Holar University College since 199057. The Holar AC-charr has responded to artificial selection in growth and performance characteristics, and is now the dominant charr breed in aquaculture in Iceland. While clearly a derived form, it has retained general limnetic craniofacial morphotype (Figure 1). In this study we compare SB-charr from Lake Thingvallavatn and AC-charr because i) SB charr represents an extensively studied and derived form of charr, that has been separated from Anadromous fish for approx. 10,000 years, ii) of the availability of abundant AC material and iii) we wanted an extreme contrast, because of budget reasons we could only sequence 8 samples at the time. This rather extreme contrast is justified as the data and other studies58,59 building on this data illustrate (see discussion).

45fcb1ac-f974-4476-b9ba-899760f2b3d8_figure1.gif

Figure 1. The two contrasting morphs used in this study.

Adult individuals of the two morphs; the Holar aquaculture charr above and the small benthic charr from Lake Thingvallavatn below. Differences in size, coloration and head morphology are apparent.

The aims of this project are threefold. First, to find genes and pathways related to the development of phenotypic differences between benthic and limnetic Arctic charr morphs. Second, to screen for signals of genetic differentiation that may relate to divergence of benthic and limnetic charr. Third, we set out to verify a subset of the expression and genetic signals, in benthic and limnetic morphs. We conducted RNA-sequencing of developing offspring of two contrasting Arctic charr morphs, a small benthic charr from Lake Thingvallavatn and Icelandic aquaculture charr conforming to a limnetic morphotype. This identified candidate genetic changes and differential expression of developmental genes that may affect jaw and craniofacial traits which separate benthic and limnetic morphotypes in charr.

Methods

Sampling, rearing and developmental series

We set up crosses and reared embryos in the laboratory as previously described in 58. Embryos from four charr morphs were studied: an aquaculture charr (AC-charr) from the Holar breeding program57 and three natural morphs from Lake Thingvallavatn; small benthivorous (SB), large benthivorous (LB) and small planktivorous (PL) charr60. Samples of the first two, AC and SB-charr, which exhibit contrasting adult size and morphology (Figure 1), were collected in 2009 and material sent for developmental transcriptome sequencing. The latter two were sampled in 2010 and used for qPCR and SNP studies of selected genes. Briefly, in September 2009 we got material from spawning AC-charr from the Holar breeding program57 and spawning SB-charr collected via gill netting in Olafsdrattur in Lake Thingvallavatn. Similarly, in the 2010 spawning season SB-, LB- and PL-charr were collected from Lake Thingvallavatn. Fishing permissions were obtained from the Thingvellir National Park Commission and the owner of the Mjóanes farm. For each parent group, eggs from several females were pooled and fertilized using milt from several males from the same group. Embryos were reared at ~5°C under constant water flow and in complete darkness at the Holar University College experimental facilities in Verid, Saudárkrókur. The water temperature was recorded twice daily and the average was used to estimate the relative age of the embryos using tausomite units (τs)61. Embryos and juveniles were sampled at designated time points, placed in RNAlater (Ambion) and frozen at -20°C. Post hatching juveniles were reared at the same temperature on standard Aquaculture food. For the investigation of different tissues of adult aquaculture charr (AC) from Hólar (fish size 20–25 cm) were used. Six randomly selected individuals were killed (by cutting through spinal cord) and dissected, and samples were taken from the skin, heart, liver, gills, spleen, intestine and kidney of each fish. The samples were placed in RNAlater (Ambion) and stored at -20°C. DNA for population genetic analyses was taken from our previous study52.

Fishing in Lake Thingvallavatn was with permissions obtained both from the owner of the land in Mjóanes and from the Thingvellir National Park commission. Ethics committee approval is not needed for regular or scientific fishing in Iceland (The Icelandic law on Animal protection, Law 15/1994, last updated with Law 157/2012). Sampling was performed by Holar University College Aquaculture Research Station (HUC-ARC) personnel. HUC-ARC has an operational license according to Icelandic law on aquaculture (Law 71/2008), which includes clauses of best practices for animal care and experiments.

RNA extraction and transcriptome sequencing

Embryos of AC- and SB-charr sampled in 2009 were used for transcriptome sequencing. For this we focused on the time covering development of pharyngeal arches and morphogenesis of the head: at 141, 163, 200 and 433 τs (post fertilization). For each combination of morphs and timepoints we pooled RNA from approximately six individuals. RNA extraction and following steps were performed as described earlier58,62. The embryos were dechorionated and homogenized with a disposable Pellet Pestle Cordless Motor tissue grinder (Kimble Kontes, Vineland, NJ, USA) and RNA was extracted into two size-fractions using the Ambion mirVana kit (Life Technologies, Carlsbad, CA, USA). The high molecular weight fraction was further used for mRNA-seq and RNA quality was analysed using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). First and second strand cDNA synthesis, fragmentation, adapter ligation and amplification were performed using the mRNA-Seq 8-Sample Prep Kit (Illumina, San Diego, CA, USA) according to manufacturer’s instructions. Sequencing was performed at DeCode genetics (Reykjavík, Iceland) using SOLEXA GAII technology (Illumina, San Diego, CA, USA). The sequencing reads were deposited into the NCBI SRA archive under BioProject identifier PRJNA239766 and with accession numbers: SRX761559, SRX761571, SRX761575, SRX761577, SRX761451, SRX761461, SRX761490 and SRX761501.

The embryos sampled in 2010 were used for qPCR expression analyses. RNA was extracted from six whole embryos, in two replicates (two repetitions X three fish) (AC and SB sampled at 161 and 200 τs). For the extraction of RNA from heads of AC, SB, LB and PL, 12 embryos (two repetitions X six fish) at 178, 200 and 216 τs were used. Embryos were dechorionated and decapitated in front of the pectoral fin. RNA extraction and cDNA preparation were performed as described previously in 58. Similarly, RNA was extracted from a small piece (approximately 2 mm2) of skin, heart, liver, gill, spleen, intestine and liver from six adult AC-charr.

Analyses of RNA-seq data and mapping to Salmon EST contigs

As no S. alpinus genome is available and de novo assembly of the 36 bp reads yielded an excessive number of short contigs we chose to assess expression and genetic variation by mapping the reads to 59336 S. salar expressed sequence tag (EST) contigs from the SalmonDB [63, downloaded 22. March 2012] and the Arctic charr mitochondrial genome [55, NC_000861].

To estimate expression, reads were aligned with RSEM version 1.1.18 with default parameters. RSEM distributes reads that map to multiple locations to the most likely contig, using expectation maximization64. The read counts for contigs with the same annotation were pooled because some genes were represented by more than one contig, and due to whole genome duplication salmonids have closely related paralogous genes30,32. Thus the expression tests are done on gene or paralog group level, instead of the contig level. In the remainder of the paper, the term ’gene’ will have this broader meaning, some genes are represented by one contig and others by two or more (indicated in all relevant tables). This brought the number of genes considered down to 16851. Lastly, genes with fewer than 800 mapped reads in the entire dataset were excluded from the analyses, yielding a total of 10496 genes.

A generalized linear model (GLM) with morph and developmental time as explanatory variables was used to find genes with different expression levels between the two charr morphotypes (groups) using the edgeR-package in R65.

        Y = Morph + Time + Error

We could not test for interaction, as biological replicates were unavailable. To obtain further insight into the expression profiles of differently expressed genes, we preformed clustering analyses on log-transformed cpm-values (counts per million; cpm-function in edgeR). The values for each gene were scaled by mean and standard deviation, and the euclidean distance used for the hclust-function in R66 with the default settings. We used the hypergeometric-test in goseq67 to test for gene ontology enrichment. Since we pooled the read-count from different contigs we could unfortunately not take gene length into account in those tests.

Assessment of differential expression with qPCR

We previously identified suitable reference genes to study Arctic charr development58. Here we examined the expression of several genes in whole charr embryos, embryonic heads and adult tissues. Primers were designed using the Primer3 tool68 and checked for self-annealing and heterodimers according to the MIQE guidelines69 (S1 Table). Primers for genes with several paralogs were designed for regions conserved among paralogs. For natterin, primers for the different paralogs were designed to match regions differing in sequence. Relative expression was calculated using the 2−∆∆Ct method70. For the calculation of relative expression of genes in whole embryos, the geometric mean expression of three reference genes, β-Actin, elongation factor 1α and Ubiquitin-conjugating enzyme E2 L3, was used for normalization. For visual comparisons among samples, the normalized expression was presented as relative to the expression in AC at 161 τs (calibration sample). For the embryonic head samples IF5A1 and ACTB were used as reference genes and a biological replicate of AC at 178 (τs) as the calibrator sample. Standard errors of relative expression were calculated from the standard errors (SE) of the ∆CT-values with the formula 2-(∆∆Ct+SE) = minimum fold expression and 2-(∆∆Ct−SE) = maximum fold expression. The statistical analysis was performed using the ∆CT-values with a two-way ANOVA with GLM function in R.

       Y = Morph + Time + M x T + Error

Normal distribution of residuals was confirmed for all data. For the study of expression in the embryonic head we followed a significant morph effect in the ANOVA with Tukey’s post-hoc honest significant difference test, on relative expression ratios (∆CTs).

Polymorphisms in the Arctic charr transcriptome

For analysis of genetic variation we mapped the reads to the salmon contigs, this time using the Burrows-Wheeler Aligner (BWA)71 with a seed length of 25, allowing two mismatches. We re-mapped the reads, since BWA allows short indels (RSEM does not) but disregarding them leads to many false SNPs close to indels. To extract candidate polymorphic sites from the Arctic charr transcriptome we ran VarScan272 with minimum coverage of 50 reads and minimum minor allele frequency of 0.1 on reads mapped to each S. salar contig for all of the 8 timepoints and morph combinations. This was done separately for reads that mapped uniquely to one contig only (UNI) and reads that mapped to two or more contigs (REP). These SNP-candidates were further processed in R66. SNP-candidates at 90% frequency or higher in all samples were disregarded, as they reflect differences between Arctic charr and S. salar and are not the focus of this study. SNP-candidates with poor coverage in specific samples - i.e. coverage of five or fewer reads in three or four samples of each morph - were removed. As the SNP analysis was done on individual contigs, differences among paralogs appear in the data. However, since each sample is a pool of few individuals, it is very unlikely that we have the same frequency of true SNPs in the samples. This property was used to remove variants that are most likely due to expressed paralogs. Using Fisher exact tests to evaluate differences between samples, only SNPs that were significantly different between samples with a p < 0.05 (with no multiple testing correction) were chosen for further examination. As equal cDNA input from individuals in sample cannot be assumed, due to expression differences among them and stochastic processes in sample preparation, read numbers were summed over the four samples from each morph for the comparison between them. A conservative approach was taken to look for differences between morphs. We focused on SNP-candidates that showed differences in frequency between morphs, without adjusting for multiple testing (Fisher exact test, p > 5%). We extracted the most interesting candidates by filtering by frequency difference between the morphs (delta). SNP-candidates with the highest frequency difference (delta > 95%) were manually processed and redundant candidates removed. A similar approach was used to mine for polymorphisms in Arctic charr mtDNA (NC_000861), using S. salar mtDNA as the outgroup (NC_001960.1).

We wrote a python script to predict the impact of SNPs within the mRNA sequences. Polymorphisms were categorized according to their location (3’UTR, coding, 5’UTR), and those within the coding region into synonymous or non-synonymous.

Verification of candidate SNPs

We chose 12 candidate SNPs for verification (see below). The candidates were verified using a similar approach as previously52; first, we conducted genomic comparisons of the Salmon genome, ESTs and short contigs from the preliminary assembly of the Arctic charr transcriptome. This allowed us to infer the placement of the putative polymorphism in the locus, and design paralog specific primers for PCR (less than 1 kb amplicons) for verification of the 12 candidate SNPs (S2 Table). MJ tetrad machine was used for PCR and the program was 5 min. at 95°C, followed by 35 cycles of 30 sec. at 52°C, 1 min. at 72°C, 30 sec. at 95°C, ending with 12°C while waiting on the human. Each individual was genotyped by first amplifying the region of interest using PCR, followed by ExoSAP (Affymetrix), direct sequencing (BigDye) and finally run on an Applied Biosystems 3500xL Genetic Analyzer (Hitachi). Raw data was base-called using the Sequencing Analysis Software v5.4 with KBTMBasecaller v1.41 (Applied Biosystems). Ab1 files were run through Phred and Phrap and imported to Consed for visual editing of ambiguous bases and putative polymorphisms, and for trimming primers. The FASTA files were aligned with ClustalW online [73, http://www.ebi.ac.uk/Tools/msa/clustalw2/] and manually inspected in Genedoc74. All sequences where deposited to Genbank as popsets under the accession numbers KP019972-KP020026.

Comparative genomic analyses of sequence polymorphisms

Comparative genomics showed that several verified SNPs affected evolutionarily constrained parts of the mitochondrial genome. Two approaches were used: performing a BLAST search on salmon ESTs (May 2013) and retrieving multiZ alignments of vertebrates from the UCSC genome browser (in September 2013). This yielded several hundred sequences from related fish and other vertebrates. The list was reduced to 20 sequences for visualization, by keeping members of the major taxa but removing more closely related sequences, aligned with ClustalW and manually adjusted in Genedoc. The species and genome versions used are; Human (Homo sapiens, hg19), Lamprey (Petromyzon marinus, petMar1), Fugu (Takifugu rubripes, fr2), Medaka (Oryzias latipes, oryLat2), Stickleback (Gasterosteus aculeatus, gasAcu1), Tetraodon (Tetraodon nigroviridis, tetNig2), Zebrafish (Danio rerio, danRer6). We also downloaded from NCBI the sequence of whole or partial mtDNA from several fish species; Brown trout (Salmo trutta, JQ390057 and AF148843), Broad whitefish (Coregonus nasus, JQ390058), Legless searsid (Platytroctes apus, AP004107), Pacific menhaden (Ethmidium maculatum, AP011602), Icefish (Salanx ariakensis, AP006231 and HM151535), Chain pickerel (Esox niger, AP013046) and Western Pacific roughy (Hoplostethus japonicus, AP002938). The three mitochondrial variants (numbered by the S. alpinus mtDNA - NC_000861) are; m1829G>A (CCACGTTGTGAAACCAAC[G/A]TCCGAAGGTGGATTTAGCAGT), m3211T>C (CGTGCAGAAGCGGGCATAAG[T/C]ACATAAGACGAGAAGACCCT) and m3411C>T (CTCTAAGCACCAGAATTT[C/T]TGACCAAAAATGATCCGGC).

Results

RNA sequencing characteristics

Each sample yielded good quality data, with sequencing depth from 49 to 58 million (average: 55 million) reads. To quantify the expression levels, the reads were aligned to a salmon EST-assembly63. Around 20% of the reads mapped uniquely to the EST data (S3 Table). A further 30% mapped to two or more contigs, probably representing paralogous genes, recent duplications or repeat-like elements within transcribed regions. A substantial fraction of the RNA-sequencing reads did not map to the contigs from S. salar. Analyses of those reads require an Arctic charr genome sequence or transcriptome assembly from longer and paired end reads.

Differential expression during Arctic charr development

For the expression analysis, ESTs were collapsed into 16851 “genes” or paralog groups (see the Methods for the broader meaning of gene). We only considered genes (total of 10496) with 800 or more reads mapped and tested for differential expression using the edgeR-package65. We detected considerable changes in the transcriptome during Arctic charr development (Figure 2a). The expression of 1603 and 2459 genes differed significantly between developmental timepoints at the 1% and 5% levels of false discovery rate (FDR), respectively (S1 file). The difference was most pronounced between pre-hatching (timepoints: 141, 163, 200 τs) and post hatching embryos (timepoint 433 τs), as more than 70% of the genes with FDR below 1% had higher expression in the latter (Figure 2a). According to Gene Ontology analyses, six separate GO categories are significant (below 10% FDR). The most drastic changes were seen in processes related to glycolysis (GO:0006096, FDR = 0.0009), were the expression of 19 out of 25 genes changed during this developmental period. The other five classes that were differentially expressed during charr development are: ion transport (GO:0006811, FDR = 0.027), blood coagulation (GO:0007596, FDR = 0.03), DNA repair (GO:0006281, FDR = 0.08) and two immune related categories (GO:0019882, FDR = 0.08, GO:0006955, FDR = 0.09). Those results probably reflect developmental changes and/or differences in the environment of embryos before and after hatching.

45fcb1ac-f974-4476-b9ba-899760f2b3d8_figure2.gif

Figure 2. Heatmap of differentially expressed genes in the Arctic charr developmental transcriptome.

Two morphs (SB and AC) are represented, at four timepoints. (A) The 1603 genes with expression difference among time points, here clustered into four groups . (B) The 71 genes differentially expressed between morphs, are clustered into 4 groups for each of the two morphs. High expression is indicated by blue and low expression by beige.

Differential expression between Arctic charr morphs

We were especially interested in genes showing expression differences between the two Arctic charr morphs as they might implicate pathways involved in the ecological divergence among charr populations. In the data 296 genes were differentially expressed (FDR < 5%) between the morphs (141 higher in SB and 152 higher in AC, S1 file). Among genes with higher expression in SB-charr two biological GO categories were enriched: blood coagulation (GO:0007596, p = 0.001) and proteolysis (GO:0006508, p = 0.002). Recall, expression of blood coagulation factors also differed between developmental stages (see above). In AC-charr, genes in three categories: respiratory electron transport chain (GO:0022904, p = 0.0006), ATP synthesis coupled electron transport (GO:0042773, p = 0.002) and neurotransmitter transport (GO:0006836, p = 0.009) have higher expression. The first two GO categories both relate to energy generation in mitochondria and could reflect higher expression of genes with mitochondrial functions in AC-charr.

At more stringent FDR (1%), 31 genes were higher expressed in SB and 40 genes higher in AC-charr (Figure 2b, Table 1 and Table 2). These genes have diverse functional annotations. The genes with higher expression in each morph were clustered into 4 groups, which aggregated genes of similar function. For instance SB cluster 3 has three immune related genes: Complement factor D (9), H-2 class I histocompatibility antigen L-D alpha chain (2) and Sushi domain-containing protein 2 (4) and one gene with unknown function (Table 1). Note, however, that immune genes were not significantly enriched in the GO comparison of morphs.

Table 1. Differentially expressed genes, with higher expression in the SB morph from Lake Thingvallavatn.

NRUnigene.DescriptionNR.contigslogFClogCPMFDRCluster
3766Histone H3 embryonic18.712.747.80E-035S-1
5103Natterin-like protein62.757.127.76E-007S-2
356A7J6M9 Putative uncharacterized protein n175R12.334.663.30E-006S-1
6697Q1KY05 Main olfactory receptor-like protein53.126.929.96E-005S-1
8151Sushi domain-containing protein 242.205.550.0001S-3
1682Carcinoembryonic antigen-related cell adhesion
molecule 1
32.553.830.0002S-1
6228Protein FAM98A21.964.760.0003S-1
7531STAM-binding protein-like22.072.620.0005S-1
6712Q1M160 Myc-regulated DEAD box protein11.673.230.0009S-1
2300Cytosolic sulfotransferase 331.732.130.0009S-1
2063Complement factor D71.796.420.0016S-3
3326Galectin-3-binding protein A41.793.850.0017S-4
3169Flocculation protein FLO1121.864.050.0017S-1
1203B5XDY0 H-2 class I histocompatibility antigen L-D
alpha chain
21.702.120.0028S-3
9183UPI000065D844 UPI000065D844 related cluster21.975.550.0028S-1
2909Epidermis-type lipoxygenase 341.684.840.0029S-1
4884Myeloperoxidase42.206.780.0029S-1
10003Uridine phosphorylase 141.513.000.0047S-1
2513Desmoglein-1-alpha11.592.800.0054S-2
377A7SJA8 Predicted protein (Fragment)11.732.500.0055S-3
9204UPI00006A2900 UPI00006A2900 related cluster26.383.260.0064S-1
9642UPI00017B1B0F UPI00017B1B0F related cluster12.001.920.0064S-2
1965Coiled-coil domain-containing protein 13622.152.320.0064S-2
9260UPI0000F1D4BA PREDICTED: hypothetical protein11.802.410.0065S-2
738Adseverin81.585.510.0073S-1
9678UPI00017B4479 UPI00017B4479 related cluster12.181.970.0074S-4
8339Testin41.504.930.0080S-2
6840Q4SNH3 Chromosome 8 SCAF14543 whole genome
shotgun sequence
11.424.000.0080S-1
1668Carbohydrate sulfotransferase 612.092.080.0090S-4
8341Testisin22.012.760.0090S-4
6373Protein asteroid homolog 161.294.240.0090S-4

logFC – log Fold Change

logCPM – log Counts Per Million

FDR – False Discovery Rate

The cluster numbering corresponds to Figure 1.

Table 2. Differentially expressed genes, with higher expression in the AC morph.

NRUnigene.DescriptionNR.contigslogFClogCPMFDRCluster
3465Glutathione S-transferase P 11-8.352.451.12E-019A-2
2475Dehydrogenase/reductase SDR family member 72-4.882.159.67E-014A-3
6945Q6NWE8 Sb:cb283 protein (Fragment)3-6.083.022.15E-013A-2
399A8DW32 Predicted protein1-5.326.384.27E-010A-1
9682UPI00017B4B48 UPI00017B4B48 related cluster2-3.702.812.61E-008A-2
9817Uncharacterized protein ART25-12.636.898.23E-008A-2
6724Q2L0Z2 Putative ATP-dependent RNA helicase1-3.411.891.88E-007A-2
1197B5XD10 Vacuolar proton pump subunit G 11-4.302.101.84E-006A-2
5325Nucleoside diphosphate kinase B1-9.857.632.51E-006A-1
9205UPI0000D5B923 PREDICTED: myelin basic protein
isoform 1
3-2.493.459.18E-006A-3
6377Protein broad-minded1-2.112.744.75E-005A-1
5711Pistil-specific extensin-like protein1-2.162.600.0002A-3
3203Formin-like protein 207-1.981.950.0002A-3
9315UPI0000F2EC69 PREDICTED: hypothetical protein2-5.604.570.0005A-2
363A7RFV0 Predicted protein (Fragment)2-1.744.960.0010A-3
6937Q6AZT1 MGC81677 protein3-2.063.810.0014A-2
3756Histone H13-2.264.540.0017A-2
1133B5DGN9 Creatine kinase-17-4.725.500.0017A-3
309A1IMH7 CD80-like protein12-1.944.290.0017A-2
7651Serine protease ami2-1.545.900.0017A-3
9935Uncharacterized protein C7orf63 homolog1-1.871.910.0025A-2
5219Nostrin2-2.553.380.0029A-2
1855Chondroitin sulfate N-acetylgalactosaminyltransferase 25-2.566.140.0034A-1
10203Xylose isomerase6-1.552.430.0035A-3
2249Cytochrome c oxidase subunit 311-1.7811.150.0035A-3
18040S ribosomal protein S3-B2-5.318.670.0050A-1
1227B6NBL3 Putative uncharacterized protein3-1.592.950.0050A-2
5055NADH-ubiquinone oxidoreductase chain 62-1.482.650.0061A-3
4634Metallothionein A1-3.335.440.0064A-2
342A5C0J4 Putative uncharacterized protein2-2.582.470.0064A-2
9698UPI00019258B4 PREDICTED: similar to epithelial cell
transforming sequence 2 oncogene protein partial
1-2.062.940.0064A-2
5878Pro-opiomelanocortin B1-2.045.600.0065A-2
2248Cytochrome c oxidase subunit 29-2.219.830.0074A-2
1246B8JI87 Novel protein similar to vertebrate collagen
type VI alpha 3 (COL6A3) (Fragment)
1-1.693.160.0080A-3
7994Sperm-associated antigen 51-2.073.710.0080A-2
9515UPI000175F90F PREDICTED: similar to pleckstrin
homology domain containing family A member 7
1-2.001.870.0090A-2
1124B5DDZ4 Acta1 protein1-1.522.620.0090A-2
1127B5DG94 2-peptidylprolyl isomerase A2-2.565.670.0090A-1
9175UPI000054A3C0 PREDICTED: apolipoprotein B3-1.324.090.0090A-4
9671UPI00017B3C62 UPI00017B3C62 related cluster1-1.511.920.0096A-1

For column header explanation, see footer of Table 1.

The results suggest mitochondrial function and blood coagulation genes are differentially expressed between the morphs, but due to few samples used in the RNA-sequencing, qPCR verification was needed.

Validation of gene expression differences in whole embryos and paralog specific expression of natterin genes

The data highlights genes likely to differ in expression between embryos of SB and AC-charr. Of the nine genes subjected to qPCR analyses of whole embryos, five were confirmed to be differentially expressed between AC and SB at 161 or 200 τs (Figure 3, S4 Table and S2 file). Three genes, Nattl, Alkaline phosphatase (Alp) and Lysozyme (Lyz), had significantly higher expression in SB. The other two, Keratin-associated protein 43 (Krtap43) and Poly polymerase 6 (Parp6) had higher expression in AC embryos (Figure 3, S4 Table). No morph and time interaction was detected for any of the genes.

45fcb1ac-f974-4476-b9ba-899760f2b3d8_figure3.gif

Figure 3. qPCR validation of candidates from transcriptome in whole embryos of Arctic charr.

Relative expression of 9 genes (AI) analysed by qPCR in the small benthic (SB) charr from Lake Thingvallavatn and aquaculture (AC) charr at two different developmental timepoints (161 and 200 $\tau s$). 5 genes were differentially expressed between the two morphs (Alp, Krtap4-3, Lyz, Nattl, Parp6), while 4 further genes did not show significant expression differences between morphs (Cgat2, Cox6B1, Ndub6, Ubl5), see Table S3. Error bars represent standard deviation calculated from two biological replicates.

As some of the genes are represented by different contigs or even paralogs, we set out to disentangle the expression of one paralog group in detail. The qPCR primers used above matched conserved gene regions and thus estimate the combined expression of several paralogs. We chose to measure the expression of three different natterin paralogs (nattl1, 2 and 3), in part because this understudied gene was first characterized as a toxin produced by a tropical fish75,76. We studied nattl expression in several developmental stages in AC-, SB- and PL-charr as well as in selected tissues of adult AC-charr. The expression level of the three paralogs differed between morphs and timepoints (Figure 4 and S5 Table). Overall nattl2 had the highest expression in all morphs. The nattl1 had higher expression in embryos of PL-charr than in AC- and SB-charr, while nattl2 and nattl3 were more expressed in SB-embryos.

45fcb1ac-f974-4476-b9ba-899760f2b3d8_figure4.gif

Figure 4. Relative expression of Nattl and its three paralogs during charr development in different morphs.

The expression is graphed for different morphs (SB, AC and PL) at four developmental timepoints (161, 200, 256 & 315 $\tau s$, relative to AC-charr at timepoint 161. A) General {Nattl} expression along charr development. BD) Expression of Nattl paralogs 1–3. ANOVA showing the variation among morphs is summarized in Table S4.

In order to evaluate the hypothesis that nattl genes have immune-related functions we studied expression in adult tissues (in AC-charr). The nattl expression was highest in the gills, followed by expression in kidney, skin and spleen. Low expression levels were detected in liver, intestine and heart (S1 Figure and S5 Table). The three nattl paralogs followed different patterns, whilst each of them showed significant expression differences among tissues. Nattl1 was mainly expressed in spleen and kidney, while nattl2 showed a significantly higher expression in skin, liver and in gills. Similarly, the relative expression of nattl3 was highest in the gills and skin. This indicates that the three nattl paralogs are expressed in a tissue specific manner, and also differently during the development of the three charr morphs studied here.

Expression differences in the developing heads of benthic and limnetic charr morphs

To study the craniofacial divergence between sympatric Arctic charr morphs we used qPCR to study 8 genes with expression difference in the RNA-seq data (all higher in SB). We focused on genes with known craniofacial expression in zebrafish development77 and compared two benthic (SB, LB) and two limnetic charr (AC, PL). We analyzed heads at three time-points (178, 200 and 218 τs) as this period overlaps with early stages of craniofacial skeletal formation in Arctic charr78,79. The qPCR confirmed the higher expression of seven out of these eight genes in the head of benthic charr compared to limnetic charr (Figure 5, S2 Figure and S3 file). These seven genes are Claudin 4 (Cldn4), adseverin (Scin), Junction plakoglobin (Jup), Lipolysis stimulated lipoprotein receptor (Lsr), Major vault protein (Mvp), Transforming growth factor beta receptor II (Tgfbr2) and Vitamin D receptor a (Vdra). The eighth gene, Retinoic acid receptor gamma-A (Rarg) gave a small but significant response in the head, but the effects were reversed, i.e. the expression was higher in AC. The expression difference of the seven genes was, in almost all cases, consistent over the three time-points studied (See S2 Figure).

45fcb1ac-f974-4476-b9ba-899760f2b3d8_figure5.gif

Figure 5. Expression differences of craniofacial candidate genes in developing head of Arctic charr morphs.

Relative expression ratios, calculated from the qPCR data, were subjected to an ANOVA to test the expression differences amongst four charr groups and three close time points ($\tau s$). The underlined gene names reflect significant difference between SB and AC-charr. A post hoc Tukey's test (HSD) was performed to determine the effects of morphs, time and morph-time interaction (M X T). White boxes represent low expression, while black boxes represent high expression. The shading represents significant different expression between the samples (p = 0.05, NS = not significant).

Analyses of polymorphism in Arctic charr transcriptome

The RNA-seq data also revealed segregating variations with large frequency differences between charr morphs. To uncover candidate SNPs we mapped the reads to all of the S. salar EST-contigs. Filtering on coverage yielded 165,790 candidate SNPs (Table 3); of those 66.569 came from reads that mapped uniquely and 57.009 candidate SNPs from reads that mapped to more than one contig; with limited overlap between lists. Assuming that the expression of paralogous genes is stable, then differences among paralogs appear as SNPs at similar frequency in all samples. By requiring variant frequency differences (p < 0.05, uncorrected) between samples we reduced the list of candidates by two thirds, yielding over 20.000 candidate SNPs. Note, that as cDNA from charr families was sequenced (not a population sample), estimates of SNP frequencies are imprecise. To err on the side of caution, we chose SNP candidates with 50% or higher frequency difference between morphs for further study. The candidate SNPs were also summarized by frequency of the derived allele, in reference to the S. salar sequence. This gave 672 and 872 SNPs at higher frequency, in AC-charr and SB-charr, respectively. The uniquely and multiply mapped reads, revealed approximately similar numbers of candidate SNPs. Gene ontology analysis showed that for derived SNPs in SB, there was an excess of variants in genes related to translation, both as a broad category and specific subgroups (S6 Table). There was also enrichment of SNPs in genes related to DNA-mediated transposition, DNA integration, DNA replication and oxidation-reduction process. No GO categories were enriched for high frequency derived SNPs in AC. Furthermore, functional effects of the candidate SNPs (UTR, synonymous and non-synonymous) were predicted. The distribution among those categories did not differ between variants detected by uniquely or repeatedly mapped reads, χ2[3] = 2.59, p = 0.46 (S7 Table).

Table 3. Candidate SNPs in the Arctic charr transcriptome, filtered by coverage, difference between sample and morphs and frequency difference between morphs.

For Delta > 0.95 we show the number of SNP-candidates before the redundant ones were removed.

SNP-candidatesMorphUniRepTotal
Total9623174341165790
Filter coverage6656957009113776
Diff. Bwn. samples214172225242869
Diff. Bwn. morphs113851295323974
Delta > 0.5AC396285672
Delta > 0.5SB526353872
Delta > 0.75AC9568159
Delta > 0.75SB15595248
Delta > 0.95AC171330
Delta > 0.95SB29433

SNP-candidates are found by mapping to S. salar ESTs. From UNIquely or REPeatedly mapped RNA-reads. Delta: Differences in allele frequency between morphs, categorized by which morph had the higher derived allele frequency.

A total of 60 candidate SNPs are nearly fixed in one morph, with frequency difference between morphs above 95% (after manual inspection of contigs and SNP position three candidates were removed since they represented the same SNP). Of these “fixed” SNPs 46 came from uniquely mapped reads and 14 from reads that mapped more than twice (Table 4 and Table 5). For the SNPs from uniquely mapped reads, 17 are fixed in AC-charr and 29 in SB-charr. The few genes with two or more polymorphic sites were; Keratin type II cytoskeletal 3 (KRT3), Cysteine sulfinic acid decarboxylase (CSAD) and DNA-directed RNA polymerase I subunit RPA12 (RPA12) with 5, 5 and 2 SNPs respectively. KRT3 and CSAD had significant differentiation in both SB and AC. Similarly, 14 SNPs with large differentiation between morphs were predicted from reads that mapped on two or more contigs (Table 5). Of these, we found two variants in the mitochondrial 60S ribosomal protein L36 (RPL36) and variants in 4 other mitochondrial genes (28S ribosomal protein S18a mitochondrial (MRPS18A), Apoptosis-inducing factor 1 mitochondrial (AIFM1), Isocitrate dehydrogenase [NADP] mitochondrial (acIDH1) and Protein S100-A1 (S100A1)), all at higher frequency in AC-charr. PCR and Sanger sequencing was used to confirm SNPs in DNA2-like helicase (DNA2), a gene with nuclear and mitochondrial function, and two other genes Uroporphyrinogen decarboxylase (UROD), and Mid1-interacting protein 1-like (MID1IP1) (S2 Table). The candidate variant Eukaryotic translation initiation factor 4 gamma 2 (EIF4G2) was not substantiated by the PCR/sequencing.

Table 4. SNP candidates from uniquely mapped reads.

(a) Higher frequency in AC morph
ContigAnnotationPosRefVarFreq-
SB
Freq-
AC
Effect
SS2U026955Keratin type II cytoskeletal 3300AT0.0000.984synonymous
SS2U026955Keratin type II cytoskeletal 3309GA0.0000.996synonymous
SS2U033960Cysteine sulfinic acid decarboxylase192CG0.0001.0005prime
SS2U033960Cysteine sulfinic acid decarboxylase416GT0.0000.961G to V
SS2U033960Cysteine sulfinic acid decarboxylase945CA0.0040.956synonymous
SS2U043396Eukaryotic translation initiation factor 2-alpha
kinase 1
134AG0.0001.0005prime
SS2U043886Transcription cofactor HES-61308TC0.0001.0005prime
SS2U044339Intraflagellar transport protein 52 homolog479TC0.0211.000D to G
SS2U045168Putative Peptide prediction1275GA0.0001.0003prime
SS2U045328E3 ubiquitin-protein ligase DTX3L388GA0.0000.977synonymous
SS2U045990Low-density lipoprotein receptor-related protein 1135TC0.0000.969synonymous
SS2U048125a Transmembrane protein 131-like480GA0.0001.000synonymous
SS2U052747Uridine 5’-monophosphate synthase914GA0.0000.951synonymous
SS2U054542Mediator of RNA polymerase II transcription
subunit 20
474CT0.0270.995synonymous
SS2U056193SUMO-conjugating enzyme UBC996AT0.0001.0003prime
SS2U057101ETS domain-containing protein Elk-3440CG0.0001.0003prime
SS2U058860Voltage-dependent anion-selective channel
protein 2
681GT0.0001.0003prime
(b) Higher frequency in SB morph
SS2U000399Insulin-like growth factor-binding protein 7598CA1.0000.0003prime
SS2U004484Titin387GA0.9900.010synonymous
SS2U026826L-asparaginase363CT1.0000.000H to Y
SS2U026955Keratin type II cytoskeletal 3116CA0.9960.031T to N
SS2U026955Keratin type II cytoskeletal 3264CT0.9700.008synonymous
SS2U026955Keratin type II cytoskeletal 3317CT1.0000.002T to M
SS2U033960Cysteine sulfinic acid decarboxylase363CT1.0000.0255prime
SS2U033960Cysteine sulfinic acid decarboxylase387CT1.0000.030synonymous
SS2U033960Cysteine sulfinic acid decarboxylase657TC0.9900.031synonymous
SS2U034322Cyclin-C1094AG1.0000.0003prime
SS2U034431Dolichyl-diphosphooligosaccharide–protein
glycosyltransferase subunit 2
436GA0.9920.000G to S
SS2U036025Nuclear receptor coactivator 436GA1.0000.0435prime
SS2U040590Glutamyl-tRNA(Gln) amidotransferase subunit A
homolog
478GA0.9720.000synonymous
SS2U045606Superkiller viralicidic activity 2-like 2500CT1.0000.000synonymous
SS2U047816Squalene synthase1139GA1.0000.029synonymous
SS2U048063Lysine-specific demethylase NO66669CT1.0000.000synonymous
SS2U050394UPF0542 protein C5orf43 homolog596GA1.0000.000synonymous
SS2U050880a Transmembrane protein 131-like901CT1.0000.000A to V
SS2U052076Eukaryotic translation initiation factor 3 subunit A824CT1.0000.031synonymous
SS2U053417RNA polymerase-associated protein LEO1454GA1.0000.049synonymous
SS2U054333Scaffold attachment factor B2382GA0.9990.000V to M
SS2U054705Cell division protein kinase 4122AG0.9710.0003prime
SS2U054965DNA-directed RNA polymerase I subunit RPA12106GA1.0000.0005prime
SS2U054965DNA-directed RNA polymerase I subunit RPA12411TG1.0000.000synonymous
SS2U055120Chromatin modification-related protein MEAF6350AC1.0000.000H to P
SS2U055153Complexin-11191CA1.0000.0313prime
SS2U057635Mitogen-activated protein kinase 14B1370AT1.0000.0263prime
SS2U058169Transmembrane protein 50A1214CG0.9730.0003prime
SS2U058802Signal recognition particle 54 kDa protein607TA0.9690.000C to S

a Those genes are distinct paralogs

Table 5. SNP candidates with significant difference frequency between AC and SB morphs, from reads that mapped to two or more contigs.

ContigAnnotationPosRefVarFreq-
SB
Freq-
AC
Effect
SS2U004839Actin alpha sarcomeric/cardiac550AC0.0150.9993prime
SS2U02129828S ribosomal protein S18a mitochondrial462AC0.0001.000synonymous
SS2U041264Apoptosis-inducing factor 1 mitochondrial341CT0.0000.952synonymous
SS2U054211aCytoplasmic dynein 1 intermediate chain 2136TC0.0180.974synonymous
SS2U054362aQ08CA8 Dynein cytoplasmic 1 intermediate
chain 2
945AG0.0001.000synonymous
SS2U055923Bystin1623AC0.0000.9833prime
SS2U058758Protein S100-A1253CT0.0000.984synonymous
SS2U059000Isocitrate dehydrogenase [NADP]
mitochondrial
1654TC0.0000.9753prime
SS2U05914660S ribosomal protein L36263TG0.0091.000synonymous
SS2U05914660S ribosomal protein L36470AC0.0091.000synonymous
SS2U036667Heterogeneous nuclear ribonucleoprotein K813CT1.0000.0225prime
SS2U042873RNA polymerase-associated protein LEO1460GA1.0000.000synonymous
SS2U058455Adenylosuccinate lyase1616CT1.0000.0003prime
SS2U058906Mid1-interacting protein 1-like350GT0.9850.000E to D

a Those genes are distinct paralogs

Polymorphism and expression of Arctic charr mtDNA

Considering the enrichment of differentially expressed genes related to mitochondrial energy metabolism (above), and high frequency candidate SNPs in several genes with mitochondrial function in AC-charr we decided to study the mitochondrial transcriptome further. The charr studied here reflect metabolic extremes, the aquaculture charr was bred for growth while the small benthic morph is thought to have experienced natural selection for slow metabolism and retarded growth45,80. Although mRNA preparation protocols were used for generating cDNA for the RNA-sequencing, a substantial number of reads came from non-polyadenylated sequences. By mapping the reads to mtDNA sequence of Arctic charr we could estimate expression and infer polymorphism both in genes and intergenic regions. There was a clear difference in sequencing coverage, with more than twice as many reads mapped from the AC- compared to SB-charr (mean fold difference 2.27, Wilcoxon test, p < 0.0004). Note, as only two types of fish are compared, it is impossible to determine the polarity of expression divergence.

The mapped RNA-reads were used to identify polymorphism and divergence in the entire mitochondrial chromosome. The polymorphisms were found by mapping to mtDNA from a Canadian S. alpinus55, but ancestral vs. derived status inferred by comparison to S. salar mtDNA. Bioinformatics revealed 82 candidate sites, including 35 that represent divergence between Icelandic and Canadian charr. A total of 20 candidate SNPs had high (more than 50%) frequency difference between SB and AC-charr (Figure 6). There was no bias in the distribution of derived SNPs, 11 on the AC branch and 9 in SB. Note, the frequency distribution is most irregular as we sequenced embryos of related individuals (see Materials and Methods), not a population sample. The divergence between Iceland and Canada is particularly little in the 12s and 16s ribosomal RNA genes. Curiously in those genes were two SNPs differing strongly in frequency between morphs (Figure 6). To confirm and better estimate the frequency of variants in the ribosomal genes, we PCR amplified and sequenced two ~550 bp regions in the rRNA genes, comparing three morphs (PL, LB and SB) from Lake Thingvallavatn (Figure 7A, C and E, S2 Table). The 12s polymorphism (m1829G>A) differed significantly between the morphs (χ2[2] = 8.6, p = 0.014), and was at highest frequency in the SB (0% in PL, 12.5% in LB and 75% in SB). Similarly m3411C>T in the 16s was enriched in SB (62.5%) but found at lower frequency in PL (0%) and LB (12.5%) (it differed significantly between morphs, χ2[2] = 9.3333, p = 0.009). The Sanger sequencing also revealed three other polymorphisms in the amplified region, not seen in the transcriptome. Among those m3211T>C in the 16s gene was at 75% frequency in LB, but not found in the other morphs (χ2[2] = 19.76, p < 0.0001).

45fcb1ac-f974-4476-b9ba-899760f2b3d8_figure6.gif

Figure 6. Genetic divergence in the mtDNA between SB- and AC-charr.

The frequency differences between morphs of candidate SNPs, estimated from the RNA-sequencing, graphed along the mtDNA chromosome. The SNPs indicate whether the derived allele is of higher frequency in SB (black dots) or AC (open circles). Sites of divergence between the Icelandic stocks and the Canadian reference sequence are indicated by triangles. The two black boxes represent the 12s (left) and 16s (right) rRNA genes, and gray boxes the 14 coding sequences.

In order to gauge the potential functionality of those variants we aligned the rRNA genes from nearly hundred fishes and several vertebrates. The position affected by m1829G>A and m3211T>C, in the 12s and 16s rRNAs, are not well conserved in fishes or vertebrates (Figure 7B and Figure 7D). However m3411C>T, in the 16s rRNA, alters a position that is nearly invariant in 100 fish genomes (Figure 7F). The only exception is Pacific menhaden, which curiously also has T in this position. This region could not be aligned properly in other vertebrates. Thus m3411C>T alters a conserved position, but probably not very drastically as the introduced allele is tolerated in another fish species.

45fcb1ac-f974-4476-b9ba-899760f2b3d8_figure7.gif

Figure 7. Comparative genomics and population genetic differentiation in Arctic charr at 3 mtDNA locations.

Aligned are several fish genomes, with Lamprey or humans as outgroups, reflecting a 38 bp window around each of the 3 positions (*). A, C, E) Frequency of each of those variants in three Arctic charr populations from Lake Thingvallavatn (PL, LB and SB). A total of 8 individuals were genotyped from each morph, see methods. B) Alignment of variant m1829G>A in the 12s rRNA gene in fishes, using humans as an outgroup. D) Similar alignment of a 16s variant, m3211T>C and F) alignment of variant m3411C>T in the 16s rRNA gene.

NR;Unigene.Description;NR.contigs;logCPM;logFC.morph;logFC.T163;logFC.T200;logFC.T433;FDR.morph;FDR.time;Contigs
1;1;1;2.612484616;-0.225481503;-0.278873417;-0.508896253;-1.277691095;0.747951606;0.249821976;SS2U035087
2;1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon;4;3.761073585;-0.037996738;-0.049978651;-0.214128465;-0.287112446;0.960307572;0.980234357;"SS2U018930;SS2U019592;SS2U039760;SS2U056048
3;1-acyl-sn-glycerol-3-phosphate acyltransferase gamma;5;6.641146181;-0.093743693;0.20009448;-0.238354348;-0.208334783;0.88435103;0.892076961;"SS2U004154;SS2U024396;SS2U048217;SS2U050512;SS2U055142
4;1-acylglycerol-3-phosphate O-acyltransferase ABHD5;1;2.133993891;0.49521831;0.023509611;1.118101512;2.324916304;0.401948832;2.13E-05;SS2U003655
5;1-phosphatidylinositol-3-phosphate 5-kinase;7;5.260268835;-0.38689962;-0.088015122;-0.391712255;-0.113987932;0.465032901;0.944528332;"SS2U002134;SS2U003087;SS2U004468;SS2U006309;SS2U044956;SS2U047955;SS2U052927
6;1-phosphatidylinositol-45-bisphosphate phosphodiesterase delta-3-A;3;2.341483498;0.431834652;0.057641376;1.060875195;1.827508509;0.493633343;0.005589471;"SS2U009205;SS2U022276;SS2U023144
7;1-phosphatidylinositol-45-bisphosphate phosphodiesterase delta-4;2;2.264883133;0.792747977;-0.097681734;0.863114439;1.270034862;0.20906477;0.102563277;"SS2U022953;SS2U040057
8;1-phosphatidylinositol-45-bisphosphate phosphodiesterase gamma-2;10;3.139508136;0.713188012;0.090462865;0.212322212;1.519687203;0.212528803;0.017349671;"SS2U000135;SS2U008251;SS2U009524;SS2U009982;SS2U011052;SS2U017905;SS2U041812;SS2U042526;SS2U043584;SS2U056769
9;10 kDa heat shock protein mitochondrial;6;7.799633887;-0.862114545;-0.110956924;-1.044483907;-1.673802659;0.165095491;0.031331196;"SS2U004717;SS2U005582;SS2U025053;SS2U028699;SS2U050788;SS2U053447
10;116 kDa U5 small nuclear ribonucleoprotein component;3;7.000213188;0.486918577;-0.367990988;-0.215463197;-1.133955925;0.360141222;0.246758537;"SS2U003487;SS2U033745;SS2U052181
11;12-dihydroxy-3-keto-5-methylthiopentene dioxygenase;3;3.911848586;-0.723764887;-0.025457788;-0.792186481;-0.944435434;0.212472367;0.298942451;"SS2U002791;SS2U012428;SS2U056621
12;14 kDa phosphohistidine phosphatase;4;5.244222064;-0.563773699;0.160789827;-0.661330316;-0.340718352;0.344871943;0.628141603;"SS2U004897;SS2U053842;SS2U056111;SS2U057209
13;14-3-3 protein beta/alpha-1;8;9.171313556;0.095614462;0.035511723;0.041090437;-0.19442016;0.88064536;0.988917928;"SS2U009914;SS2U014987;SS2U015011;SS2U038869;SS2U042558;SS2U054347;SS2U058799;SS2U058972
14;14-3-3 protein beta/alpha-2;7;8.957141502;-0.257379786;0.006140266;-0.363991125;-0.695437341;0.656199827;0.592338255;"SS2U003874;SS2U007688;SS2U010089;SS2U013448;SS2U025534;SS2U058852;SS2U058868
15;14-3-3 protein epsilon;8;8.667318144;-0.361145939;0.160119787;-0.156305471;-0.294410443;0.502884329;0.90900795;"SS2U006277;SS2U014641;SS2U032523;SS2U036452;SS2U039538;SS2U052995;SS2U056978;SS2U057649
16;14-3-3 protein eta;1;6.600213965;-0.42158307;0.410260345;0.019051378;-0.168586586;0.428541857;0.814944143;SS2U056360
17;14-3-3 protein gamma-1;3;4.327066324;0.085545254;0.321091797;1.355584646;2.381201245;0.914552447;0.000281919;"SS2U020224;SS2U033530;SS2U046718
18;14-3-3 protein gamma-2;1;4.510861236;0.765738803;0.639947348;2.663870715;3.600739346;0.379845184;2.59E-05;SS2U048701
19;14-3-3 protein zeta;3;6.875487454;-0.335563171;0.145279794;-0.292905615;-0.232669211;0.573194022;0.917840857;"SS2U000658;SS2U051741;SS2U058533
20;14-3-3 protein zeta/delta;2;7.428260156;0.427798182;-0.140877964;0.108542693;0.392081067;0.408709329;0.851513193;"SS2U016659;SS2U057927
21;14-alpha-glucan-branching enzyme;2;3.042413021;0.892710917;0.106418452;1.375322749;1.922063649;0.207401194;0.017934593;"SS2U026017;SS2U028058
22;15 kDa selenoprotein;2;6.253954585;-0.80529457;0.195399573;-0.999801208;-1.240689902;0.227415942;0.115855957;"SS2U056695;SS2U058959
23;15-hydroxyprostaglandin dehydrogenase [NAD+];4;5.251629565;0.183546552;0.135330677;-0.141998365;0.570774647;0.775348257;0.678955932;"SS2U010083;SS2U038717;SS2U057358;SS2U058207
24;17-beta-hydroxysteroid dehydrogenase 14;3;5.185466229;0.31567291;-0.109987412;0.159190769;0.444034696;0.574472376;0.834254827;"SS2U006677;SS2U033760;SS2U058371
25;2'3'-cyclic-nucleotide 3'-phosphodiesterase;2;8.077383965;-0.218525486;0.367732124;-0.01492356;-0.600848565;0.715628762;0.42991632;"SS2U042736;SS2U056939
26;2-acylglycerol O-acyltransferase 2-A;5;2.458927261;0.428000924;0.274668818;0.437833355;0.635828036;0.481229598;0.840235407;"SS2U009307;SS2U011994;SS2U029798;SS2U041706;SS2U052121
27;2-amino-3-carboxymuconate-6-semialdehyde decarboxylase;1;2.922103392;-0.097074048;-0.182504475;-0.036632019;0.038738542;0.912496047;0.998274817;SS2U052082
28;2-amino-3-ketobutyrate coenzyme A ligase mitochondrial;3;4.52535201;-0.263590115;0.139116392;-0.012539865;0.253874869;0.640419788;0.979824326;"SS2U006645;SS2U007274;SS2U058373
29;2-aminoethanethiol dioxygenase;3;3.497900691;-0.321419314;0.36456262;0.001915721;-0.193790211;0.575455719;0.854908114;"SS2U012362;SS2U047445;SS2U055590
30;2-hydroxyacyl-CoA lyase 1;3;5.200967177;0.404513275;-0.131646828;0.359150262;0.759905736;0.481095107;0.449404569;"SS2U003230;SS2U014852;SS2U051718
31;2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1;4;4.173033846;-0.060619158;-0.089973463;-0.374285612;-0.852045365;0.927630034;0.457784822;"SS2U021246;SS2U041176;SS2U043117;SS2U048634
32;2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2;4;2.698309587;-0.684351189;-0.022296588;-0.710502718;-0.073093846;0.212528803;0.656271941;"SS2U020964;SS2U023809;SS2U024697;SS2U041648
33;2-oxoglutarate dehydrogenase mitochondrial;6;6.656969148;0.397717801;0.079638703;0.771518231;1.686102482;0.518480722;0.012739482;"SS2U015898;SS2U027755;SS2U030749;SS2U040484;SS2U042130;SS2U047766
34;2-oxoisovalerate dehydrogenase subunit alpha mitochondrial;2;4.705668206;0.789048388;-0.012571542;0.588147276;1.170022501;0.17017232;0.145758626;"SS2U014675;SS2U043384
35;2-oxoisovalerate dehydrogenase subunit beta mitochondrial;3;6.331992067;-0.184567693;0.013826487;-0.205154242;-0.00152498;0.752680634;0.989961948;"SS2U018362;SS2U049433;SS2U055173
36;24-dienoyl-CoA reductase mitochondrial;1;4.961320773;0.315645176;-0.149037773;0.297366645;1.09369054;0.584644751;0.103584083;SS2U044796
37;25-hydroxycholesterol 7-alpha-hydroxylase;2;3.214382274;-0.222220961;-0.223709437;-0.091760327;0.622466861;0.719686573;0.477324406;"SS2U035375;SS2U055951
38;26S protease regulatory subunit 4;22;8.533552286;-0.367148747;-0.057635086;-0.650346274;-0.945953669;0.515375627;0.295606682;"SS2U000228;SS2U010151;SS2U011752;SS2U011753;SS2U012688;SS2U012933;SS2U013810;SS2U013811;SS2U013935;SS2U020575;SS2U020715;SS2U023197;SS2U036612;SS2U036613;SS2U037972;SS2U040248;SS2U042370;SS2U045373;SS2U047133;SS2U052199;SS2U058522;SS2U058550
39;26S protease regulatory subunit 6A;18;8.253677439;-0.17228184;-0.189995137;-0.675727099;-0.853383109;0.782910075;0.422594111;"SS2U004029;SS2U008932;SS2U009083;SS2U009894;SS2U010142;SS2U011408;SS2U015041;SS2U033647;SS2U033648;SS2U033649;SS2U033650;SS2U040816;SS2U044050;SS2U044051;SS2U050352;SS2U051921;SS2U056860;SS2U059095
40;26S protease regulatory subunit 6B;7;7.126090461;0.009834256;-0.242365433;-0.30581166;-0.745460691;0.989071431;0.642677932;"SS2U002692;SS2U007157;SS2U009523;SS2U028733;SS2U038597;SS2U057664;SS2U058595
41;26S protease regulatory subunit 7;5;8.376547781;-0.257052465;-0.134738764;-0.710431026;-0.872461241;0.675286814;0.374988036;"SS2U000417;SS2U015749;SS2U029765;SS2U034493;SS2U058796
42;26S protease regulatory subunit 8;18;8.230321707;0.05270079;-0.225639511;-0.608322928;-1.023704563;0.941180218;0.309606235;"SS2U007232;SS2U008594;SS2U009304;SS2U013322;SS2U032380;SS2U032381;SS2U032382;SS2U037695;SS2U037696;SS2U040409;SS2U040410;SS2U042743;SS2U049808;SS2U050333;SS2U050641;SS2U051057;SS2U054751;SS2U057654
43;26S protease regulatory subunit S10B;6;7.65562158;-0.203435027;-0.167311415;-0.5384128;-0.974634262;0.72409881;0.306164559;"SS2U000606;SS2U006113;SS2U010477;SS2U044081;SS2U054959;SS2U057794
44;26S proteasome complex subunit DSS1;6;6.887659987;-0.774315096;0.181132612;-0.858714018;-1.019254593;0.208104783;0.175993729;"SS2U000916;SS2U008456;SS2U020081;SS2U020626;SS2U051119;SS2U059023
45;26S proteasome non-ATPase regulatory subunit 1;4;8.917522541;0.078399876;-0.010462799;-0.228966095;-0.21244349;0.90594062;0.981227175;"SS2U012719;SS2U036322;SS2U046523;SS2U057465
46;26S proteasome non-ATPase regulatory subunit 10;4;4.90235986;-0.118297419;-0.214363556;-0.601840846;-1.064868546;0.849579808;0.242014629;"SS2U010644;SS2U032193;SS2U040530;SS2U056913
47;26S proteasome non-ATPase regulatory subunit 11;6;7.109670026;-0.235081304;0.001951351;-0.288034111;-0.641287535;0.681065747;0.66409136;"SS2U018584;SS2U022136;SS2U022137;SS2U040196;SS2U046815;SS2U057146
48;26S proteasome non-ATPase regulatory subunit 12;9;7.13409551;-0.235948125;0.018766092;-0.390877057;-0.580103261;0.681690774;0.685201513;"SS2U011282;SS2U011613;SS2U012390;SS2U012391;SS2U020242;SS2U028769;SS2U053263;SS2U054778;SS2U054831
49;26S proteasome non-ATPase regulatory subunit 13;5;7.292928441;0.025174124;-0.076697993;-0.36904132;-0.774026842;0.972489366;0.534208271;"SS2U007629;SS2U012279;SS2U012322;SS2U038513;SS2U057731
50;26S proteasome non-ATPase regulatory subunit 14;6;7.77420275;-0.355224582;-0.030704389;-0.65508484;-1.140569281;0.541332864;0.163843833;"SS2U005680;SS2U012949;SS2U020653;SS2U024034;SS2U041001;SS2U056977
51;26S proteasome non-ATPase regulatory subunit 2;5;8.186805901;0.2427975;-0.135570494;-0.086270125;-0.313739032;0.675271169;0.976879367;"SS2U005642;SS2U041625;SS2U042926;SS2U051028;SS2U053413
52;26S proteasome non-ATPase regulatory subunit 3;3;7.899890138;-0.067114858;-0.110041332;-0.295265304;-0.626164189;0.917998;0.743983161;"SS2U000463;SS2U052183;SS2U058552
53;26S proteasome non-ATPase regulatory subunit 4;7;7.908815489;0.017318065;-0.133741333;-0.34933992;-0.511466553;0.981079705;0.851731748;"SS2U015561;SS2U029338;SS2U034552;SS2U036709;SS2U046483;SS2U051587;SS2U058665
54;26S proteasome non-ATPase regulatory subunit 5;7;4.869183843;-0.306241424;-0.078909095;-0.580967681;-1.229394279;0.5836968;0.114239288;"SS2U012282;SS2U013293;SS2U017568;SS2U018206;SS2U038185;SS2U048666;SS2U055930
55;26S proteasome non-ATPase regulatory subunit 6;6;7.346566165;-0.42608542;-0.138841393;-0.69599827;-1.110825811;0.434436135;0.189179238;"SS2U011170;SS2U033952;SS2U033953;SS2U054527;SS2U056315;SS2U057164
56;26S proteasome non-ATPase regulatory subunit 7;7;7.470946361;-0.400421495;-0.097805971;-0.772007365;-1.179148614;0.463117205;0.118341502;"SS2U010858;SS2U013445;SS2U019052;SS2U036834;SS2U048656;SS2U056703;SS2U056777
57;26S proteasome non-ATPase regulatory subunit 8;3;6.64641373;-0.313928299;-0.096714438;-0.646478964;-0.895896348;0.571700033;0.32586206;"SS2U016668;SS2U019905;SS2U058847
58;26S proteasome non-ATPase regulatory subunit 9;2;5.773556489;-0.459594803;0.038376908;-0.716815273;-0.782819986;0.436328465;0.383842162;"SS2U040755;SS2U058260
59;28 kDa heat- and acid-stable phosphoprotein;3;6.171767363;0.109339439;-0.128155366;-0.421473556;-0.63830012;0.864347717;0.725119944;"SS2U011068;SS2U047224;SS2U049439
60;28S ribosomal protein S11 mitochondrial;1;5.203915635;0.572861559;-0.470927495;0.190371684;0.239793828;0.323318217;0.728972213;SS2U056130
61;28S ribosomal protein S12 mitochondrial;3;5.427490213;-0.031845995;0.205320505;-0.487298981;-0.309306247;0.970050329;0.757679185;"SS2U017647;SS2U048115;SS2U051845
62;28S ribosomal protein S14 mitochondrial;1;5.128497011;-0.47441701;-0.185092754;-0.777058943;-1.240536351;0.396288574;0.139626385;SS2U055706
63;28S ribosomal protein S15 mitochondrial;4;5.501242752;-0.688277631;-0.073414991;-0.716551038;-0.696018301;0.215652119;0.509195192;"SS2U018180;SS2U028076;SS2U052753;SS2U056438
64;28S ribosomal protein S16 mitochondrial;5;5.422273596;-0.699601404;0.056692936;-0.775105155;-1.095121695;0.23827036;0.195950521;"SS2U019386;SS2U028793;SS2U038914;SS2U051880;SS2U055666
65;28S ribosomal protein S17 mitochondrial;1;3.698179019;-0.781067796;0.013740296;-0.250256492;-0.436823351;0.140788912;0.890427338;SS2U052929
66;28S ribosomal protein S18a mitochondrial;4;4.84299107;-0.63831584;0.042755114;-0.506040998;-0.669871827;0.238808747;0.576445807;"SS2U004691;SS2U021298;SS2U045590;SS2U057048
67;28S ribosomal protein S18b mitochondrial;3;5.508608188;-0.688429994;-0.020533866;-0.912165529;-0.9583115;0.234125835;0.224932303;"SS2U006506;SS2U012078;SS2U058582
68;28S ribosomal protein S18c mitochondrial;2;4.448254959;-1.242911541;0.191601846;-1.035553529;-1.265491362;0.067934031;0.096962162;"SS2U037873;SS2U054775
69;28S ribosomal protein S2 mitochondrial;4;4.156927822;0.506744993;-0.31807741;0.562772152;0.628290306;0.41233619;0.439788593;"SS2U009977;SS2U022108;SS2U022557;SS2U047360
70;28S ribosomal protein S21 mitochondrial;3;4.954435408;-0.897268292;0.297736865;-0.653767446;-0.430177306;0.186885004;0.608125734;"SS2U010989;SS2U010990;SS2U058039
71;28S ribosomal protein S22 mitochondrial;1;4.762075071;-0.167867263;0.084831144;-0.317253119;-0.204942406;0.780057818;0.92373926;SS2U052885
72;28S ribosomal protein S23 mitochondrial;3;5.638584938;-0.514081797;0.016439839;-0.671154438;-0.728621347;0.374825667;0.480773721;"SS2U043224;SS2U050518;SS2U055511
73;28S ribosomal protein S24 mitochondrial;1;4.856519781;-0.489962276;0.024117224;-0.610672455;-0.633718218;0.377381943;0.558476639;SS2U058450
74;28S ribosomal protein S25 mitochondrial;1;4.733867569;-0.790927035;-0.293817414;-1.317193043;-1.865835929;0.238329153;0.022618824;SS2U055707
75;28S ribosomal protein S26 mitochondrial;1;4.345595394;-0.68315987;0.112223002;-0.618365597;-0.460598881;0.286197167;0.71545054;SS2U047977
76;28S ribosomal protein S27 mitochondrial;4;4.731640031;-0.374618796;0.011200305;-0.345597686;-0.441173895;0.489805548;0.851600158;"SS2U034246;SS2U038384;SS2U041131;SS2U046008
77;28S ribosomal protein S28 mitochondrial;1;4.505666963;-1.028222902;0.188322294;-0.779662945;-0.661260452;0.122884871;0.447183828;SS2U058926
78;28S ribosomal protein S29 mitochondrial;1;6.597229352;0.013732677;0.000722904;-0.336260958;-0.237481976;0.985691689;0.947300455;SS2U056402
79;28S ribosomal protein S30 mitochondrial;4;5.240659923;-0.47584848;-0.095550638;-0.457352316;-0.508734647;0.37782767;0.815165066;"SS2U006502;SS2U006503;SS2U047973;SS2U052792
80;28S ribosomal protein S31 mitochondrial;3;4.964838903;-0.27951276;-0.037148585;-0.380414415;-0.321805332;0.635125282;0.919480863;"SS2U021444;SS2U047048;SS2U049762
81;28S ribosomal protein S33 mitochondrial;5;4.898911448;-0.550446693;0.053994499;-0.499990827;-0.739544151;0.296349215;0.472180402;"SS2U003850;SS2U007973;SS2U021798;SS2U036682;SS2U050839
82;28S ribosomal protein S34 mitochondrial;4;5.864085834;-0.040451501;0.040315913;-0.013629602;0.001429209;0.954288703;0.999555498;"SS2U016987;SS2U038996;SS2U056137;SS2U057302
83;28S ribosomal protein S35 mitochondrial;3;5.25740306;-0.052795555;-0.199060509;-0.479862344;-0.533731855;0.941737343;0.829968986;"SS2U002256;SS2U009639;SS2U055926
84;28S ribosomal protein S36 mitochondrial;4;5.43307422;-0.934530715;0.102337898;-0.864566062;-0.519667864;0.137182715;0.463025962;"SS2U013845;SS2U049500;SS2U049950;SS2U051234
85;28S ribosomal protein S5 mitochondrial;1;6.178530985;0.023186476;-0.189013133;-0.131140732;-0.00132169;0.975059328;0.992628004;SS2U052099
86;28S ribosomal protein S6 mitochondrial;1;3.879335649;-0.816243792;-0.00025288;-0.88482926;-0.894100441;0.14962952;0.233227714;SS2U058065
87;28S ribosomal protein S7 mitochondrial;5;4.940592381;-0.454465422;-0.111763416;-0.469467501;-0.74687189;0.411646096;0.619699253;"SS2U013106;SS2U013628;SS2U018480;SS2U054257;SS2U058541
88;28S ribosomal protein S9 mitochondrial;6;5.495421144;-0.111091831;-0.00708016;-0.236545782;-0.190926038;0.862085985;0.983437449;"SS2U006485;SS2U006486;SS2U015726;SS2U020944;SS2U050118;SS2U050872
89;3 beta-hydroxysteroid dehydrogenase type 7;3;3.48671514;-0.174860214;-0.066814768;-0.04981122;0.841527514;0.780265362;0.275895001;"SS2U036774;SS2U042422;SS2U056948
90;3'(2')5'-bisphosphate nucleotidase 1;7;4.849270994;-0.287841079;-0.166702746;-0.775132734;-1.13972179;0.645678099;0.198949412;"SS2U001678;SS2U025147;SS2U025148;SS2U034920;SS2U034921;SS2U042847;SS2U052711
91;3'-5' exoribonuclease 1;4;4.470430025;0.02279238;-0.103065279;-0.406062083;-0.700904269;0.975719147;0.646306174;"SS2U028207;SS2U028632;SS2U039327;SS2U052405
92;3'-5' exoribonuclease CSL4 homolog;1;5.868949005;0.739119967;-0.267601046;-0.044932866;0.061994606;0.147679878;0.967595152;SS2U049850
93;3-hydroxy-3-methylglutaryl-coenzyme A reductase;2;4.557159487;-0.135559043;0.362867627;0.230801883;0.476259806;0.82407821;0.892356028;"SS2U003076;SS2U055576
94;3-hydroxyacyl-CoA dehydrogenase type-2;4;6.698483102;0.146351129;-0.08990561;-0.15821137;0.060377516;0.832016291;0.994002833;"SS2U020095;SS2U023246;SS2U038157;SS2U057905
95;3-hydroxyanthranilate 34-dioxygenase;4;2.806312613;-0.784021498;0.329333314;0.343323797;-0.062139894;0.180123247;0.916947218;"SS2U006638;SS2U009895;SS2U009973;SS2U057913
96;3-hydroxybutyrate dehydrogenase type 2;2;6.274424607;0.125435903;-0.396453228;-0.511679208;-1.088528138;0.839803511;0.273416156;"SS2U034664;SS2U057977
97;3-hydroxyisobutyrate dehydrogenase mitochondrial;7;7.236679117;0.090590492;-0.001247416;0.010709836;0.274198658;0.888504031;0.971597254;"SS2U005697;SS2U008752;SS2U008753;SS2U009052;SS2U021506;SS2U039141;SS2U057617
98;3-hydroxyisobutyryl-CoA hydrolase mitochondrial;2;2.954833712;0.489151851;-0.700792529;0.195210922;0.437298775;0.46067388;0.432283716;"SS2U008687;SS2U045701
99;3-ketoacyl-CoA thiolase mitochondrial;6;7.05521624;0.319854961;-0.134167994;0.299334467;1.958246854;0.557600901;8.39E-06;"SS2U011940;SS2U013257;SS2U015495;SS2U053380;SS2U054192;SS2U058414
100;3-mercaptopyruvate sulfurtransferase;3;4.70146886;0.014550328;-0.2324319;-0.062748838;0.189315049;0.984455486;0.935887704;"SS2U015199;SS2U055198;SS2U057713
101;3-oxo-5-alpha-steroid 4-dehydrogenase 2;8;2.274953094;0.427539106;1.032875885;1.562785999;3.637908425;0.517605632;8.21E-10;"SS2U006473;SS2U010008;SS2U011564;SS2U045326;SS2U047204;SS2U047887;SS2U050754;SS2U052433
102;3-oxo-5-alpha-steroid 4-dehydrogenase 3;2;3.073396424;-1.395723203;0.04121692;-1.061170922;-1.280657543;0.034617034;0.108381277;"SS2U002622;SS2U039252
103;3-oxo-5-beta-steroid 4-dehydrogenase;2;1.881881779;-0.740713388;0.696503513;0.310488911;0.985125315;0.212033724;0.476871638;"SS2U030161;SS2U058423
104;3-oxoacyl-[acyl-carrier-protein] reductase;1;3.451483003;-0.198678211;-0.231535703;-0.861951831;-1.103377868;0.7674607;0.229366518;SS2U055976
105;3-oxoacyl-[acyl-carrier-protein] synthase mitochondrial;5;3.273610448;0.312415135;-0.247170465;-0.355600779;-0.716089603;0.589502488;0.723844181;"SS2U022454;SS2U022455;SS2U029834;SS2U033191;SS2U040650
106;3-phosphoinositide-dependent protein kinase 1;6;5.056949073;0.282977969;-0.045338465;0.438192622;0.787280815;0.638424983;0.442699727;"SS2U003646;SS2U025719;SS2U036683;SS2U052207;SS2U052369;SS2U053579
107;32-trans-enoyl-CoA isomerase mitochondrial;1;5.060236514;0.315473526;-0.291278524;0.162652782;1.062159009;0.604924622;0.093632544;SS2U042027
108;35 kDa SR repressor protein;3;1.824060517;-0.090947361;-0.420009053;-0.984891278;-1.342427156;0.907995592;0.16417265;"SS2U011092;SS2U011093;SS2U044490
109;39S ribosomal protein L1 mitochondrial;1;5.177307963;-0.323738425;-0.049886142;-0.438618079;-0.915599747;0.571141184;0.386355032;SS2U055407
110;39S ribosomal protein L10 mitochondrial;3;5.715818581;-0.223386475;-0.142401725;-0.621886385;-0.791811989;0.727156104;0.528478991;"SS2U034633;SS2U034634;SS2U050021
111;39S ribosomal protein L11 mitochondrial;3;6.129370374;-0.208981484;-0.151828368;-0.459695098;-0.683866177;0.728722982;0.674289321;"SS2U040747;SS2U045809;SS2U058684
112;39S ribosomal protein L12 mitochondrial;2;4.536190266;0.358462055;-0.24703571;0.335856908;-0.279791463;0.534445794;0.74165247;"SS2U033104;SS2U049370
113;39S ribosomal protein L13 mitochondrial;1;5.438678271;-0.827448493;0.130593086;-0.955806005;-1.099559439;0.170893461;0.117431739;SS2U056671
114;39S ribosomal protein L14 mitochondrial;2;5.311487374;-0.34798134;-0.134347978;-0.459120653;-0.725428274;0.516992493;0.602359158;"SS2U032587;SS2U057378
115;39S ribosomal protein L15 mitochondrial;4;5.035147451;-0.241334197;-0.067527135;-0.452019819;-0.599939486;0.678434104;0.702954532;"SS2U022409;SS2U023636;SS2U049843;SS2U053236
116;39S ribosomal protein L16 mitochondrial;4;6.648619769;-0.08631435;-0.149228221;-0.350240078;-0.469581461;0.898604882;0.900911339;"SS2U016460;SS2U016461;SS2U038594;SS2U057356
117;39S ribosomal protein L17 mitochondrial;2;5.86768091;-0.744910067;-0.101125029;-1.035016689;-1.501523128;0.188940894;0.030490293;"SS2U050385;SS2U056116
118;39S ribosomal protein L18 mitochondrial;1;6.309002485;-0.386618785;-0.176737656;-0.831236584;-0.857913722;0.523052614;0.38211911;SS2U056937
119;39S ribosomal protein L19 mitochondrial;1;5.896177159;-0.131518567;0.2313727;-0.063457004;-0.484252344;0.836544192;0.705272715;SS2U053687
120;39S ribosomal protein L2 mitochondrial;1;5.552983554;-0.318211192;-0.032473287;-0.404551784;-0.407090663;0.571141184;0.86445178;SS2U057312
121;39S ribosomal protein L20 mitochondrial;1;5.278083083;-0.077848179;-0.046665525;-0.020785944;-0.096000264;0.912496047;0.999555498;SS2U053878
122;39S ribosomal protein L21 mitochondrial;8;4.224376319;-0.75590183;0.024464784;-1.008466385;-0.90382141;0.21602768;0.231624465;"SS2U010704;SS2U013739;SS2U013933;SS2U013934;SS2U038895;SS2U041427;SS2U047273;SS2U058407
123;39S ribosomal protein L22 mitochondrial;3;5.244309686;-0.516914069;-0.058946198;-0.97044511;-1.263009161;0.407946904;0.121512861;"SS2U016291;SS2U050145;SS2U054934
124;39S ribosomal protein L23 mitochondrial;3;5.197030096;-0.555859684;0.19229398;-0.345522864;-0.39427692;0.326068291;0.791610133;"SS2U008492;SS2U013708;SS2U057159
125;39S ribosomal protein L27 mitochondrial;3;4.99338042;-0.704390323;0.08497137;-0.761488498;-1.06680453;0.214798302;0.164372349;"SS2U038771;SS2U053259;SS2U054678
126;39S ribosomal protein L28 mitochondrial;2;5.300619754;-0.729310668;-0.063198979;-0.601530912;-0.931788269;0.175912764;0.34163887;"SS2U008947;SS2U056040
127;39S ribosomal protein L3 mitochondrial;4;6.266283074;-0.527294063;-0.052400825;-0.866063251;-1.314892154;0.362884154;0.088288292;"SS2U013236;SS2U024727;SS2U031652;SS2U057424
128;39S ribosomal protein L30 mitochondrial;1;4.735344317;-0.754210073;0.143856598;-0.914041748;-1.123315398;0.190623113;0.088956851;SS2U051550
129;39S ribosomal protein L32 mitochondrial;1;4.917150465;-1.207786973;-0.033537429;-1.060099337;-1.582610093;0.065286136;0.04801013;SS2U053873
130;39S ribosomal protein L33 mitochondrial;2;4.092306614;-0.468501766;-0.185186067;-0.280945789;-0.347189797;0.389837556;0.966087757;"SS2U037885;SS2U051385
131;39S ribosomal protein L34 mitochondrial;4;5.34001297;-0.466183609;-0.139518328;-0.88384886;-1.113991936;0.405474401;0.159190878;"SS2U001799;SS2U013652;SS2U027329;SS2U055779
132;39S ribosomal protein L35 mitochondrial;4;4.200381326;-0.696453539;-0.116528193;-0.511421101;-0.967129586;0.19414407;0.368588042;"SS2U005254;SS2U025138;SS2U033600;SS2U058807
133;39S ribosomal protein L36 mitochondrial;3;5.417134086;-0.256032107;-0.052635576;-0.859917079;-1.382752996;0.712641469;0.090561601;"SS2U028768;SS2U043854;SS2U049454
134;39S ribosomal protein L37 mitochondrial;3;6.317582597;-0.438880049;-0.180490262;-0.759362953;-1.155591025;0.457823217;0.20864797;"SS2U035367;SS2U039089;SS2U055924
135;39S ribosomal protein L38 mitochondrial;2;6.321815641;-0.517264645;0.036483579;-0.779815842;-1.037346626;0.38455226;0.213215093;"SS2U048951;SS2U054937
136;39S ribosomal protein L39 mitochondrial;2;6.006336765;-0.220292173;-0.151526374;-0.576115522;-0.219385077;0.739930234;0.869481224;"SS2U017884;SS2U056150
137;39S ribosomal protein L4 mitochondrial;5;5.929808321;-0.673821958;-0.052850131;-0.706406445;-1.038526809;0.23991553;0.267829139;"SS2U006279;SS2U021272;SS2U040354;SS2U048841;SS2U055172
138;39S ribosomal protein L40 mitochondrial;3;4.859063827;-0.344024423;-0.135593088;-0.392436379;-0.54347843;0.526771416;0.819677819;"SS2U013862;SS2U044032;SS2U056037
139;39S ribosomal protein L41 mitochondrial;5;5.298867234;-0.708500843;-0.085491762;-0.775445792;-0.879812344;0.207942093;0.349510887;"SS2U011136;SS2U038797;SS2U046510;SS2U053454;SS2U057739
140;39S ribosomal protein L42 mitochondrial;2;5.285781179;-0.893074076;0.075815787;-0.937984443;-1.144050318;0.143209077;0.12555562;"SS2U056691;SS2U056792
141;39S ribosomal protein L43 mitochondrial;3;5.075688659;-0.667868471;0.148598192;-0.760248287;-0.613131701;0.288868875;0.478151198;"SS2U013477;SS2U029916;SS2U045833
142;39S ribosomal protein L44 mitochondrial;3;4.947761995;-0.716080827;0.087785557;-0.697400642;-0.919080401;0.207518175;0.270779186;"SS2U021189;SS2U049856;SS2U052421
143;39S ribosomal protein L45 mitochondrial;3;5.479839444;0.061910215;-0.048939014;-0.119973616;-0.123651644;0.92581635;0.999257081;"SS2U002125;SS2U053436;SS2U055391
144;39S ribosomal protein L46 mitochondrial;1;2.969432085;-0.013139161;-0.084036457;0.024065176;0.042482158;0.985731307;0.999257081;SS2U051887
145;39S ribosomal protein L47 mitochondrial;4;5.452598664;-1.185380073;0.070689257;-1.134445672;-1.432367081;0.064657979;0.045025455;"SS2U030480;SS2U038270;SS2U041538;SS2U056898
146;39S ribosomal protein L48 mitochondrial;3;4.562146376;-0.700946297;0.039715687;-0.579842882;-0.591631592;0.229378559;0.657349377;"SS2U008519;SS2U048537;SS2U048878
147;39S ribosomal protein L49 mitochondrial;2;4.486326516;-0.182048214;-0.153526508;-0.605490848;-0.623873269;0.774390104;0.66134273;"SS2U006675;SS2U057613
148;39S ribosomal protein L51 mitochondrial;8;5.411348966;-0.161927305;-0.114885415;-0.537744091;-0.543240147;0.800370964;0.756957796;"SS2U010367;SS2U010368;SS2U028986;SS2U031642;SS2U033957;SS2U038559;SS2U050380;SS2U058545
149;39S ribosomal protein L52 mitochondrial;3;4.596197253;-1.120718106;-0.01630417;-0.965513726;-1.393877698;0.093655822;0.113195853;"SS2U034174;SS2U049566;SS2U050758
150;39S ribosomal protein L54 mitochondrial;1;4.507962555;-0.882959802;0.169780439;-0.646385989;-0.809712967;0.152396943;0.39864786;SS2U057626
151;39S ribosomal protein L55 mitochondrial;3;3.975908127;-1.000802122;0.142481288;-1.122761166;-1.279517915;0.147679878;0.10775621;"SS2U012610;SS2U024044;SS2U056943
152;39S ribosomal protein L9 mitochondrial;5;4.362588472;-0.642033502;-0.06748024;-0.714157114;-0.671702207;0.236172797;0.502755469;"SS2U012626;SS2U014974;SS2U016892;SS2U034354;SS2U058394
153;4-aminobutyrate aminotransferase mitochondrial;6;5.857306038;0.369779204;-0.085999639;0.270261912;1.541498659;0.559388013;0.016387721;"SS2U007540;SS2U008525;SS2U020940;SS2U047088;SS2U055984;SS2U058364
154;4-hydroxyphenylpyruvate dioxygenase;7;7.471477059;0.009531085;0.143571144;0.226343226;0.172558698;0.989876121;0.99256856;"SS2U002649;SS2U008845;SS2U009556;SS2U037434;SS2U040342;SS2U049835;SS2U050804
155;4-hydroxyphenylpyruvate dioxygenase-like protein;3;4.71279424;-0.451320374;0.038749918;0.392310753;1.346344415;0.428541857;0.048726422;"SS2U020097;SS2U030418;SS2U046989
156;40S ribosomal protein S10;18;11.30119868;-0.566245133;0.095781669;-0.772424828;-0.422849583;0.372617733;0.586833208;"SS2U000915;SS2U001018;SS2U001035;SS2U005235;SS2U011689;SS2U015412;SS2U025130;SS2U026413;SS2U028704;SS2U028731;SS2U029920;SS2U029957;SS2U031431;SS2U031475;SS2U040262;SS2U054485;SS2U056994;SS2U058977
157;40S ribosomal protein S11;13;11.0846024;-0.714603036;0.032796699;-0.929564137;-1.145767719;0.241069703;0.150685771;"SS2U000933;SS2U001073;SS2U010369;SS2U015637;SS2U015638;SS2U020360;SS2U021165;SS2U030511;SS2U034197;SS2U034201;SS2U036659;SS2U036660;SS2U059274
158;40S ribosomal protein S12;9;11.50626806;-0.334301272;-0.045802339;-0.582038243;-0.868060664;0.585264586;0.434742481;"SS2U001002;SS2U027522;SS2U031125;SS2U031427;SS2U039231;SS2U042211;SS2U043295;SS2U058547;SS2U059037
159;40S ribosomal protein S13;9;11.20602473;-0.77640495;0.116190573;-0.833889481;-1.075463592;0.221767046;0.212906649;"SS2U001145;SS2U018056;SS2U026393;SS2U027172;SS2U028645;SS2U055478;SS2U055880;SS2U057723;SS2U058887
160;40S ribosomal protein S14;14;11.6862451;-0.517183985;-0.094925952;-0.668505245;-0.971394564;0.420996535;0.424075674;"SS2U000838;SS2U001032;SS2U001200;SS2U001201;SS2U012807;SS2U019292;SS2U027247;SS2U029947;SS2U030989;SS2U031546;SS2U053538;SS2U059039;SS2U059101;SS2U059333
161;40S ribosomal protein S15;13;10.6650474;-0.968285907;0.077580942;-0.916051548;-1.145702001;0.134577942;0.164055802;"SS2U001080;SS2U001182;SS2U005067;SS2U025502;SS2U028966;SS2U030990;SS2U033876;SS2U038535;SS2U041663;SS2U042894;SS2U050373;SS2U058602;SS2U058711
162;40S ribosomal protein S15a;5;10.68823035;-0.921118946;0.091858973;-1.159601613;-1.337547735;0.161434355;0.065963864;"SS2U001020;SS2U012306;SS2U013337;SS2U026939;SS2U058636
163;40S ribosomal protein S16;5;10.99852905;-0.890572891;0.048703209;-0.876047848;-1.232254279;0.144650498;0.116624185;"SS2U023651;SS2U028709;SS2U029680;SS2U046325;SS2U059130
164;40S ribosomal protein S17;10;10.62790481;-1.081216954;0.108655709;-1.065323677;-1.243372535;0.117402108;0.122056163;"SS2U015615;SS2U020183;SS2U024386;SS2U026931;SS2U028761;SS2U030994;SS2U036835;SS2U057787;SS2U058292;SS2U058643
165;40S ribosomal protein S18;10;11.00126195;-0.530087872;-0.112187095;-0.815517814;-0.842611783;0.382362706;0.413820925;"SS2U005896;SS2U012455;SS2U027303;SS2U027709;SS2U030953;SS2U032080;SS2U033153;SS2U034242;SS2U058858;SS2U059099
166;40S ribosomal protein S19;9;10.74680263;-0.936461633;0.172100213;-0.62120229;-1.059116276;0.124884688;0.206324332;"SS2U000506;SS2U001777;SS2U005689;SS2U026127;SS2U027732;SS2U029997;SS2U033408;SS2U039901;SS2U059236
167;40S ribosomal protein S2;12;13.3847466;-0.287685533;-0.089449389;-0.595023422;-0.693171185;0.673412751;0.658997786;"SS2U000853;SS2U001028;SS2U001064;SS2U001203;SS2U014886;SS2U016679;SS2U028691;SS2U031477;SS2U031879;SS2U042709;SS2U057652;SS2U059318
168;40S ribosomal protein S20;14;11.51310408;-1.123606917;0.086666863;-1.189320125;-1.401474341;0.105911486;0.065727435;"SS2U001023;SS2U001131;SS2U026123;SS2U028798;SS2U029926;SS2U030006;SS2U030034;SS2U030589;SS2U030988;SS2U031410;SS2U037864;SS2U051707;SS2U056297;SS2U058931
169;40S ribosomal protein S21;5;9.971255377;-0.712505946;-0.019844534;-1.170637268;-1.55730588;0.312892033;0.065228362;"SS2U001052;SS2U014999;SS2U033246;SS2U039140;SS2U057712
170;40S ribosomal protein S23;11;11.31397637;-0.62420653;0.140513699;-0.670928697;-0.658783095;0.292343658;0.4633711;"SS2U001117;SS2U009858;SS2U027752;SS2U029936;SS2U029974;SS2U030924;SS2U045936;SS2U048393;SS2U051471;SS2U058281;SS2U058827
171;40S ribosomal protein S24;14;11.37506593;-1.169912602;0.121603689;-0.871035686;-0.299725983;0.086170964;0.555260754;"SS2U001017;SS2U001129;SS2U001222;SS2U004012;SS2U005215;SS2U005677;SS2U012452;SS2U028677;SS2U029617;SS2U029956;SS2U030015;SS2U030178;SS2U052351;SS2U059182
172;40S ribosomal protein S25;14;11.71240098;-0.826317538;0.036346673;-0.943810767;-1.152731321;0.181797936;0.143163093;"SS2U001009;SS2U001019;SS2U008283;SS2U013619;SS2U016816;SS2U019939;SS2U019940;SS2U028548;SS2U030986;SS2U030992;SS2U042904;SS2U045466;SS2U058771;SS2U059219
173;40S ribosomal protein S26;9;11.41527369;-0.575362998;-0.151154802;-0.864244981;-1.146714206;0.375915742;0.262527727;"SS2U000816;SS2U001158;SS2U006441;SS2U006442;SS2U009452;SS2U021415;SS2U026934;SS2U047178;SS2U057120
174;40S ribosomal protein S27;11;11.17324708;-0.764529982;0.093747649;-0.882059351;-0.893653496;0.218528292;0.267892782;"SS2U007314;SS2U017540;SS2U026091;SS2U041457;SS2U043906;SS2U050402;SS2U057917;SS2U058259;SS2U058404;SS2U058885;SS2U058968
175;40S ribosomal protein S27-like;1;4.587840422;-0.824602768;-0.090280476;-0.411274883;1.892297561;0.228831776;0.000928931;SS2U057231
176;40S ribosomal protein S27a;8;11.56338817;-0.267112495;-0.116238839;-0.513869872;-0.622574573;0.674158364;0.730477039;"SS2U001433;SS2U004552;SS2U006860;SS2U013941;SS2U026930;SS2U031015;SS2U058980;SS2U059069
177;40S ribosomal protein S28;6;10.04924555;-0.685973088;0.018269227;-0.895847397;-1.170987091;0.281203681;0.17274397;"SS2U004476;SS2U005237;SS2U006868;SS2U013735;SS2U039927;SS2U057533
178;40S ribosomal protein S29;5;8.400378395;-0.486077579;0.083067968;-0.93534242;-1.034503195;0.499379778;0.242774046;"SS2U018512;SS2U027553;SS2U029914;SS2U042705;SS2U057853
179;40S ribosomal protein S3;14;11.60495338;-0.247658451;-0.214130542;-0.643792538;-0.859085889;0.694284351;0.488188213;"SS2U015493;SS2U016401;SS2U016417;SS2U017934;SS2U024171;SS2U024176;SS2U026025;SS2U033044;SS2U043900;SS2U054205;SS2U056275;SS2U058313;SS2U059092;SS2U059150
180;40S ribosomal protein S3-B;2;8.670060843;-5.306182618;-0.21914068;-3.9385762;-5.364323587;0.004981796;0.000497716;"SS2U024172;SS2U024242
181;40S ribosomal protein S30;6;10.32704619;-0.900386129;0.13805772;-0.847054792;-1.14204532;0.148006414;0.142776116;"SS2U004199;SS2U008473;SS2U009203;SS2U058163;SS2U058348;SS2U058857
182;40S ribosomal protein S3a;12;12.11875446;-0.323021095;-0.150127867;-0.651026828;-0.891754628;0.607795262;0.4503829;"SS2U000581;SS2U000914;SS2U001005;SS2U001074;SS2U021468;SS2U026568;SS2U026578;SS2U029723;SS2U029903;SS2U029962;SS2U041592;SS2U059300
183;40S ribosomal protein S4;10;11.81082293;-0.129648843;-0.10193833;-0.487885183;-0.616590274;0.845018766;0.723157116;"SS2U000435;SS2U000538;SS2U000921;SS2U000946;SS2U012729;SS2U027223;SS2U034080;SS2U047630;SS2U059246;SS2U059273
184;40S ribosomal protein S4 X isoform;3;8.250730069;0.338488034;-0.738463477;-0.305519637;-0.202058701;0.732107145;0.904496173;"SS2U013110;SS2U019290;SS2U036013
185;40S ribosomal protein S5;9;11.84212606;-0.307513461;-0.090244577;-0.531700762;-0.764342416;0.600901576;0.544437508;"SS2U000891;SS2U005512;SS2U025584;SS2U026048;SS2U026119;SS2U037589;SS2U053399;SS2U059230;SS2U059285
186;40S ribosomal protein S5a;7;7.634660321;-1.370832398;0.22819518;-2.011796235;-1.755119853;0.142001566;0.021179957;"SS2U001172;SS2U001205;SS2U003625;SS2U004951;SS2U010119;SS2U029949;SS2U049428
187;40S ribosomal protein S6;18;11.682397;-0.530257435;0.057048154;-0.81526032;-1.000421449;0.373338492;0.213371025;"SS2U000643;SS2U000644;SS2U000990;SS2U001115;SS2U001175;SS2U017514;SS2U020757;SS2U022066;SS2U023709;SS2U025536;SS2U026532;SS2U031843;SS2U033480;SS2U040727;SS2U040728;SS2U042826;SS2U059014;SS2U059029
188;40S ribosomal protein S7;10;10.83095385;-1.147907883;0.169981044;-1.105844186;-1.331483239;0.095429058;0.075697682;"SS2U000929;SS2U001085;SS2U001086;SS2U004603;SS2U017677;SS2U021443;SS2U022969;SS2U024798;SS2U045464;SS2U059278
189;40S ribosomal protein S8;11;11.60920508;-0.722684205;0.014943405;-0.817533938;-0.976004299;0.228831776;0.26544142;"SS2U001103;SS2U005588;SS2U005694;SS2U005892;SS2U019368;SS2U024534;SS2U029942;SS2U030975;SS2U030981;SS2U058718;SS2U059167
190;40S ribosomal protein S9;11;11.26481092;-0.62540428;-0.031252622;-0.791210032;-1.249100646;0.279233281;0.121333019;"SS2U001140;SS2U007081;SS2U012819;SS2U017419;SS2U019001;SS2U019002;SS2U030908;SS2U037501;SS2U048823;SS2U051332;SS2U059144
191;40S ribosomal protein SA;18;12.35384398;-0.206283857;-0.222297206;-0.728850128;-0.987533501;0.761525808;0.372771604;"SS2U010721;SS2U017034;SS2U023665;SS2U026750;SS2U026916;SS2U028646;SS2U028757;SS2U028805;SS2U030605;SS2U032474;SS2U035469;SS2U040825;SS2U042018;SS2U045438;SS2U050706;SS2U051930;SS2U059016;SS2U059073
192;45 kDa calcium-binding protein;3;4.552469539;0.380431642;-0.100520917;0.323487542;0.478385078;0.480260573;0.756485728;"SS2U036129;SS2U040294;SS2U050497
193;4F2 cell-surface antigen heavy chain;6;6.586196068;-0.285362074;0.3519648;0.338529986;1.377429948;0.618092793;0.046251512;"SS2U003595;SS2U015795;SS2U052061;SS2U055316;SS2U057504;SS2U057936
194;5'-3' exoribonuclease 1;2;4.436416467;0.407581376;-0.199090334;0.150193469;-0.189220305;0.486565928;0.957589653;"SS2U025174;SS2U041460
195;5'-3' exoribonuclease 2;6;7.803360787;0.377284377;-0.231776892;-0.17399318;-0.987660924;0.47893134;0.336932189;"SS2U011779;SS2U041060;SS2U047319;SS2U047944;SS2U052560;SS2U053918
196;5'-AMP-activated protein kinase catalytic subunit alpha-1;3;4.039945533;0.517418396;-0.194877035;0.185694805;0.139632619;0.350173999;0.955733822;"SS2U028935;SS2U028953;SS2U038415
197;5'-AMP-activated protein kinase catalytic subunit alpha-2;1;1.899343997;1.148852501;0.32207873;2.290360785;4.515671059;0.159590239;1.46E-10;SS2U004328
198;5'-AMP-activated protein kinase subunit beta-1;5;6.429101503;-0.248146707;0.045858315;-0.445789558;-0.775663619;0.682145835;0.476871638;"SS2U016017;SS2U017648;SS2U017924;SS2U054450;SS2U055631
199;5'-AMP-activated protein kinase subunit gamma-1;3;4.130341499;0.702971288;-0.263262424;0.317340069;0.146820115;0.246955196;0.890770079;"SS2U032396;SS2U043720;SS2U046156
This is a portion of the data; to view all the data, please download the file.
Dataset 1.Parameters and multiple testing corrected p-values for expression analysis.
The file is tab-delimited and the columns are; “Unigene.Description”: the annotation for that gene/paralog group. “NR.contigs”: number of contigs with this annotation. “logCPM”: count per million, log-scale. “logFC.morph”: Mean fold change between the morphs, log-scale. “logFC.T163”, “logFC.T200”, “logFC.T433”: Mean fold change for each timepoints compared to timepoint 141, log-scale. “FDR.morph”: P-value for morph difference, multiple testing corrected. “FDR.time”: P-value for time differences, multiple testing corrected. “Contigs”: SalmonDB id for the contigs with the specific annotation110.
Gene_Type;Gene;Morph;Relative_age;Biological_replicate;cDNA_No;Ct_value;Sample;Batch
Reference;Actb;AC;161;1;3;15.96261883;Whole_embryo;c
Reference;Actb;AC;161;2;3;16.32308578;Whole_embryo;c
Reference;Actb;AC;200;1;3;16.3116312;Whole_embryo;c
Reference;Actb;AC;200;2;3;16.69984245;Whole_embryo;c
Reference;Actb;SB;161;1;3;15.91931581;Whole_embryo;c
Reference;Actb;SB;161;2;3;15.95784521;Whole_embryo;c
Reference;Actb;SB;200;1;3;17.22946262;Whole_embryo;c
Reference;Actb;SB;200;2;3;16.48554039;Whole_embryo;c
Reference;Ub2l3;AC;161;1;3;19.2323761;Whole_embryo;c
Reference;Ub2l3;AC;161;2;3;19.53557777;Whole_embryo;c
Reference;Ub2l3;AC;200;1;3;19.7100153;Whole_embryo;c
Reference;Ub2l3;AC;200;2;3;20.06556892;Whole_embryo;c
Reference;Ub2l3;SB;161;1;3;18.85280609;Whole_embryo;c
Reference;Ub2l3;SB;161;2;3;18.97263432;Whole_embryo;c
Reference;Ub2l3;SB;200;1;3;20.86740685;Whole_embryo;c
Reference;Ub2l3;SB;200;2;3;19.65790176;Whole_embryo;c
Reference;Ef1a;AC;161;1;3;16.76741409;Whole_embryo;c
Reference;Ef1a;AC;161;2;3;16.88599777;Whole_embryo;c
Reference;Ef1a;AC;200;1;3;17.02689171;Whole_embryo;c
Reference;Ef1a;AC;200;2;3;17.05676842;Whole_embryo;c
Reference;Ef1a;SB;161;1;3;16.1616497;Whole_embryo;c
Reference;Ef1a;SB;161;2;3;16.08823395;Whole_embryo;c
Reference;Ef1a;SB;200;1;3;17.47857857;Whole_embryo;c
Reference;Ef1a;SB;200;2;3;16.80790234;Whole_embryo;c
Reference;Actb;AC;161;1;4;15.44944715;Whole_embryo;c
Reference;Actb;AC;161;2;4;15.68050861;Whole_embryo;c
Reference;Actb;AC;200;1;4;15.74295759;Whole_embryo;c
Reference;Actb;AC;200;2;4;15.98812437;Whole_embryo;c
Reference;Actb;SB;161;1;4;15.04642916;Whole_embryo;c
Reference;Actb;SB;161;2;4;15.25384712;Whole_embryo;c
Reference;Actb;SB;200;1;4;16.69416809;Whole_embryo;c
Reference;Actb;SB;200;2;4;15.51182985;Whole_embryo;c
Reference;Ub2l3;AC;161;1;4;18.98914528;Whole_embryo;c
Reference;Ub2l3;AC;161;2;4;19.06344986;Whole_embryo;c
Reference;Ub2l3;AC;200;1;4;19.48450947;Whole_embryo;c
Reference;Ub2l3;AC;200;2;4;19.50106907;Whole_embryo;c
Reference;Ub2l3;SB;161;1;4;18.56895733;Whole_embryo;c
Reference;Ub2l3;SB;161;2;4;18.72522068;Whole_embryo;c
Reference;Ub2l3;SB;200;1;4;20.6594038;Whole_embryo;c
Reference;Ub2l3;SB;200;2;4;19.26242065;Whole_embryo;c
Reference;Ef1a;AC;161;1;4;16.48565102;Whole_embryo;c
Reference;Ef1a;AC;161;2;4;16.47541046;Whole_embryo;c
Reference;Ef1a;AC;200;1;4;16.72178936;Whole_embryo;c
Reference;Ef1a;AC;200;2;4;16.8230648;Whole_embryo;c
Reference;Ef1a;SB;161;1;4;15.88469839;Whole_embryo;c
Reference;Ef1a;SB;161;2;4;15.93828535;Whole_embryo;c
Reference;Ef1a;SB;200;1;4;17.21857929;Whole_embryo;c
Reference;Ef1a;SB;200;2;4;16.40386295;Whole_embryo;c
Candidate;Nattl;AC;161;1;3;24.30113316;Whole_embryo;c
Candidate;Nattl;AC;161;2;3;24.95383644;Whole_embryo;c
Candidate;Nattl;AC;200;1;3;23.1154232;Whole_embryo;c
Candidate;Nattl;AC;200;2;3;23.16105175;Whole_embryo;c
Candidate;Nattl;SB;161;1;3;21.88699722;Whole_embryo;c
Candidate;Nattl;SB;161;2;3;23.86600208;Whole_embryo;c
Candidate;Nattl;SB;200;1;3;21.4312315;Whole_embryo;c
Candidate;Nattl;SB;200;2;3;21.58208561;Whole_embryo;c
Candidate;Alp;AC;161;1;3;24.61887646;Whole_embryo;c
Candidate;Alp;AC;161;2;3;24.90855503;Whole_embryo;c
Candidate;Alp;AC;200;1;3;24.64563656;Whole_embryo;c
Candidate;Alp;AC;200;2;3;24.88164043;Whole_embryo;c
Candidate;Alp;SB;161;1;3;23.86744976;Whole_embryo;c
Candidate;Alp;SB;161;2;3;24.1090517;Whole_embryo;c
Candidate;Alp;SB;200;1;3;24.03513622;Whole_embryo;c
Candidate;Alp;SB;200;2;3;23.89897919;Whole_embryo;c
Candidate;Cgat2;AC;161;1;3;25.23556042;Whole_embryo;c
Candidate;Cgat2;AC;161;2;3;25.13300419;Whole_embryo;c
Candidate;Cgat2;AC;200;1;3;25.34113216;Whole_embryo;c
Candidate;Cgat2;AC;200;2;3;25.33448505;Whole_embryo;c
Candidate;Cgat2;SB;161;1;3;24.65633106;Whole_embryo;c
Candidate;Cgat2;SB;161;2;3;24.73155785;Whole_embryo;c
Candidate;Cgat2;SB;200;1;3;26.19965458;Whole_embryo;c
Candidate;Cgat2;SB;200;2;3;25.16437054;Whole_embryo;c
Candidate;Cox6b1;AC;161;1;4;26.7786026;Whole_embryo;c
Candidate;Cox6b1;AC;161;2;4;27.34981537;Whole_embryo;c
Candidate;Cox6b1;AC;200;1;4;26.94288731;Whole_embryo;c
Candidate;Cox6b1;AC;200;2;4;27.02507305;Whole_embryo;c
Candidate;Cox6b1;SB;161;1;4;26.77010155;Whole_embryo;c
Candidate;Cox6b1;SB;161;2;4;26.87522507;Whole_embryo;c
Candidate;Cox6b1;SB;200;1;4;26.58977795;Whole_embryo;c
Candidate;Cox6b1;SB;200;2;4;26.95159721;Whole_embryo;c
Candidate;Krtap4-3;AC;161;1;4;24.45112514;Whole_embryo;c
Candidate;Krtap4-3;AC;161;2;4;24.41178513;Whole_embryo;c
Candidate;Krtap4-3;AC;200;1;4;24.57724857;Whole_embryo;c
Candidate;Krtap4-3;AC;200;2;4;24.6350317;Whole_embryo;c
Candidate;Krtap4-3;SB;161;1;4;24.18867779;Whole_embryo;c
Candidate;Krtap4-3;SB;161;2;4;24.52984619;Whole_embryo;c
Candidate;Krtap4-3;SB;200;1;4;26.09012604;Whole_embryo;c
Candidate;Krtap4-3;SB;200;2;4;25.35136032;Whole_embryo;c
Candidate;Lyz;AC;161;1;3;25.649189;Whole_embryo;c
Candidate;Lyz;AC;161;2;3;25.93523693;Whole_embryo;c
Candidate;Lyz;AC;200;1;3;25.97491074;Whole_embryo;c
Candidate;Lyz;AC;200;2;3;26.36354256;Whole_embryo;c
Candidate;Lyz;SB;161;1;3;23.10821247;Whole_embryo;c
Candidate;Lyz;SB;161;2;3;23.59787178;Whole_embryo;c
Candidate;Lyz;SB;200;1;3;23.74123478;Whole_embryo;c
Candidate;Lyz;SB;200;2;3;23.9212904;Whole_embryo;c
Candidate;Ndub6;AC;161;1;4;20.99980164;Whole_embryo;c
Candidate;Ndub6;AC;161;2;4;21.25080109;Whole_embryo;c
Candidate;Ndub6;AC;200;1;4;21.03236389;Whole_embryo;c
Candidate;Ndub6;AC;200;2;4;21.15505123;Whole_embryo;c
Candidate;Ndub6;SB;161;1;4;20.56019783;Whole_embryo;c
Candidate;Ndub6;SB;161;2;4;20.64115429;Whole_embryo;c
Candidate;Ndub6;SB;200;1;4;21.33388996;Whole_embryo;c
Candidate;Ndub6;SB;200;2;4;20.87278366;Whole_embryo;c
Candidate;Parp6;AC;161;1;4;23.82729721;Whole_embryo;c
Candidate;Parp6;AC;161;2;4;23.62686062;Whole_embryo;c
Candidate;Parp6;AC;200;1;4;23.44495487;Whole_embryo;c
Candidate;Parp6;AC;200;2;4;24.04651356;Whole_embryo;c
Candidate;Parp6;SB;161;1;4;23.95689011;Whole_embryo;c
Candidate;Parp6;SB;161;2;4;23.98719311;Whole_embryo;c
Candidate;Parp6;SB;200;1;4;25.88320351;Whole_embryo;c
Candidate;Parp6;SB;200;2;4;23.96511269;Whole_embryo;c
Candidate;Ubl5;AC;161;1;3;20.95245171;Whole_embryo;c
Candidate;Ubl5;AC;161;2;3;21.51314068;Whole_embryo;c
Candidate;Ubl5;AC;200;1;3;21.69692421;Whole_embryo;c
Candidate;Ubl5;AC;200;2;3;21.88066006;Whole_embryo;c
Candidate;Ubl5;SB;161;1;3;20.72139168;Whole_embryo;c
Candidate;Ubl5;SB;161;2;3;20.6724329;Whole_embryo;c
Candidate;Ubl5;SB;200;1;3;21.8654623;Whole_embryo;c
Candidate;Ubl5;SB;200;2;3;21.64883995;Whole_embryo;c
Reference;Actb;AC;161;1;1;18.93461307;Whole_embryo;a
Reference;Actb;AC;161;2;1;17.01329973;Whole_embryo;a
Reference;Actb;AC;200;1;1;18.74925942;Whole_embryo;a
Reference;Actb;AC;200;2;1;17.38162289;Whole_embryo;a
Reference;Actb;AC;256;1;1;18.32057422;Whole_embryo;a
Reference;Actb;AC;256;2;1;18.25436369;Whole_embryo;a
Reference;Actb;AC;256;3;1;19.35329826;Whole_embryo;a
Reference;Actb;AC;315;1;1;17.83992698;Whole_embryo;a
Reference;Actb;AC;315;2;1;16.75994191;Whole_embryo;a
Reference;Actb;AC;315;3;1;17.49895169;Whole_embryo;a
Reference;Actb;PL;161;1;1;16.53899002;Whole_embryo;a
Reference;Actb;PL;161;2;1;16.014712;Whole_embryo;a
Reference;Actb;PL;161;3;1;16.62383843;Whole_embryo;a
Reference;Actb;PL;200;1;1;16.97808864;Whole_embryo;a
Reference;Actb;PL;200;2;1;17.30882522;Whole_embryo;a
Reference;Actb;PL;256;1;1;17.33051229;Whole_embryo;a
Reference;Actb;PL;256;2;1;18.05678958;Whole_embryo;a
Reference;Actb;PL;315;1;1;16.8715216;Whole_embryo;a
Reference;Actb;PL;315;2;1;17.2627397;Whole_embryo;a
Reference;Actb;PL;315;3;1;18.4954958;Whole_embryo;a
Reference;Actb;SB;161;1;1;18.10572111;Whole_embryo;a
Reference;Actb;SB;161;2;1;18.47548703;Whole_embryo;a
Reference;Actb;SB;200;1;1;19.51686616;Whole_embryo;a
Reference;Actb;SB;200;2;1;16.81035177;Whole_embryo;a
Reference;Actb;SB;256;1;1;16.57099441;Whole_embryo;a
Reference;Actb;SB;256;2;1;16.65354854;Whole_embryo;a
Reference;Actb;SB;256;3;1;16.74384742;Whole_embryo;a
Reference;Actb;SB;315;1;1;18.36778707;Whole_embryo;a
Reference;Actb;SB;315;2;1;16.24909757;Whole_embryo;a
Reference;Actb;SB;315;3;1;17.70580329;Whole_embryo;a
Reference;Actb;AC;161;1;1;17.90917178;Whole_embryo;b
Reference;Actb;AC;161;2;1;17.07442431;Whole_embryo;b
Reference;Actb;AC;200;1;1;18.11745198;Whole_embryo;b
Reference;Actb;AC;200;2;1;17.60052731;Whole_embryo;b
Reference;Actb;AC;315;1;1;16.81914311;Whole_embryo;b
Reference;Actb;AC;315;2;1;16.71034441;Whole_embryo;b
Reference;Actb;PL;161;1;1;16.66228787;Whole_embryo;b
Reference;Actb;PL;161;2;1;15.9647415;Whole_embryo;b
Reference;Actb;PL;161;3;1;16.5319537;Whole_embryo;b
Reference;Actb;PL;200;1;1;16.43611547;Whole_embryo;b
Reference;Actb;PL;200;2;1;16.13770159;Whole_embryo;b
Reference;Actb;PL;256;1;1;17.09882909;Whole_embryo;b
Reference;Actb;PL;256;2;1;17.18234183;Whole_embryo;b
Reference;Actb;PL;315;1;1;15.81195874;Whole_embryo;b
Reference;Actb;PL;315;2;1;16.2744054;Whole_embryo;b
Reference;Actb;SB;161;1;1;17.00400802;Whole_embryo;b
Reference;Actb;SB;161;2;1;16.56781516;Whole_embryo;b
Reference;Actb;SB;200;1;1;19.06980825;Whole_embryo;b
Reference;Actb;SB;200;2;1;17.14548894;Whole_embryo;b
Reference;Actb;SB;256;1;1;16.26166826;Whole_embryo;b
Reference;Actb;SB;256;2;1;16.40651416;Whole_embryo;b
Reference;Actb;SB;256;3;1;16.58124201;Whole_embryo;b
Reference;Actb;SB;315;1;1;17.83687183;Whole_embryo;b
Reference;Actb;SB;315;2;1;16.24142187;Whole_embryo;b
Reference;If5a1;AC;161;1;1;24.75698158;Whole_embryo;a
Reference;If5a1;AC;161;2;1;22.82441777;Whole_embryo;a
Reference;If5a1;AC;200;1;1;23.87932034;Whole_embryo;a
Reference;If5a1;AC;200;2;1;22.32171113;Whole_embryo;a
Reference;If5a1;AC;256;1;1;22.10594451;Whole_embryo;a
Reference;If5a1;AC;256;2;1;22.04629998;Whole_embryo;a
Reference;If5a1;AC;256;3;1;21.68510554;Whole_embryo;a
Reference;If5a1;AC;315;1;1;22.9018425;Whole_embryo;a
Reference;If5a1;AC;315;2;1;21.96694438;Whole_embryo;a
Reference;If5a1;AC;315;3;1;24.27062399;Whole_embryo;a
Reference;If5a1;PL;161;1;1;22.80112612;Whole_embryo;a
Reference;If5a1;PL;161;2;1;22.57955528;Whole_embryo;a
Reference;If5a1;PL;161;3;1;23.54804685;Whole_embryo;a
Reference;If5a1;PL;200;1;1;22.08827499;Whole_embryo;a
Reference;If5a1;PL;200;2;1;21.72163439;Whole_embryo;a
Reference;If5a1;PL;256;1;1;22.48477022;Whole_embryo;a
Reference;If5a1;PL;256;2;1;21.57767856;Whole_embryo;a
Reference;If5a1;PL;315;1;1;23.0637937;Whole_embryo;a
Reference;If5a1;PL;315;2;1;21.41490463;Whole_embryo;a
Reference;If5a1;PL;315;3;1;23.79193518;Whole_embryo;a
Reference;If5a1;SB;161;1;1;24.33332821;Whole_embryo;a
Reference;If5a1;SB;161;2;1;25.15546513;Whole_embryo;a
Reference;If5a1;SB;200;1;1;25.90748262;Whole_embryo;a
Reference;If5a1;SB;200;2;1;22.28793459;Whole_embryo;a
Reference;If5a1;SB;256;1;1;22.05466539;Whole_embryo;a
This is a portion of the data; to view all the data, please download the file.
Dataset 2.qPCR data for tests of expression in charr developing embryos and adult tissues.
“Gene Type”: Designates the reference and candidate genes. “Gene”: Name of the gene. “Morph”: Which charr type the sample came from. “Relative age”: Developmental timepoint, and also indicates the samples from adult fish. “Biological replicate”: The two or more biological replicates used. “cDNA No”: Marks the cDNA isolation used. “Ct value”: Estimate of gene expression. “Sample”: Indicates the material used, whole embryos or distinct tissues. “Batch”: Demarcates distinct collections of cDNA, applies only to nattl111.
Gene_Type;Gene;Morph;Relative_age;Biological_replicate;Ct_value;cDNA_No;Tissue
Reference;If5a1;AC;178;1;23.67264175;1;Pooled_heads
Reference;If5a1;SB;178;1;23.89719925;1;Pooled_heads
Reference;If5a1;PL;178;1;23.43337822;1;Pooled_heads
Reference;If5a1;LB;178;1;23.76682129;1;Pooled_heads
Reference;If5a1;AC;178;2;23.90053482;1;Pooled_heads
Reference;If5a1;SB;178;2;23.75086136;1;Pooled_heads
Reference;If5a1;PL;178;2;23.53201408;1;Pooled_heads
Reference;If5a1;LB;178;2;23.74039001;1;Pooled_heads
Reference;If5a1;AC;216;1;23.70517731;1;Pooled_heads
Reference;If5a1;SB;216;1;22.64871025;1;Pooled_heads
Reference;If5a1;PL;216;1;22.88567162;1;Pooled_heads
Reference;If5a1;LB;216;1;22.64291;1;Pooled_heads
Reference;If5a1;AC;216;2;23.10091476;1;Pooled_heads
Reference;If5a1;SB;216;2;22.47453308;1;Pooled_heads
Reference;If5a1;PL;216;2;22.3912973;1;Pooled_heads
Reference;If5a1;LB;216;2;22.60772491;1;Pooled_heads
Reference;Actb;AC;178;1;15.91521549;1;Pooled_heads
Reference;Actb;SB;178;1;15.83242464;1;Pooled_heads
Reference;Actb;PL;178;1;15.36369801;1;Pooled_heads
Reference;Actb;LB;178;1;15.46041203;1;Pooled_heads
Reference;Actb;AC;178;2;16.16721382;1;Pooled_heads
Reference;Actb;SB;178;2;15.57671585;1;Pooled_heads
Reference;Actb;PL;178;2;15.35849991;1;Pooled_heads
Reference;Actb;LB;178;2;15.59954109;1;Pooled_heads
Reference;Actb;AC;216;1;16.65059662;1;Pooled_heads
Reference;Actb;SB;216;1;15.450243;1;Pooled_heads
Reference;Actb;PL;216;1;15.78530502;1;Pooled_heads
Reference;Actb;LB;216;1;15.58950424;1;Pooled_heads
Reference;Actb;AC;216;2;15.99549103;1;Pooled_heads
Reference;Actb;SB;216;2;15.21378136;1;Pooled_heads
Reference;Actb;PL;216;2;15.38698196;1;Pooled_heads
Reference;Actb;LB;216;2;15.51268959;1;Pooled_heads
Candidate;Mvp;AC;178;1;22.9414444;1;Pooled_heads
Candidate;Mvp;SB;178;1;21.91384125;1;Pooled_heads
Candidate;Mvp;PL;178;1;22.16065979;1;Pooled_heads
Candidate;Mvp;LB;178;1;21.95458603;1;Pooled_heads
Candidate;Mvp;AC;178;2;23.06663322;1;Pooled_heads
Candidate;Mvp;SB;178;2;21.76210022;1;Pooled_heads
Candidate;Mvp;PL;178;2;22.28490448;1;Pooled_heads
Candidate;Mvp;LB;178;2;21.67274857;1;Pooled_heads
Candidate;Mvp;AC;216;1;23.39944839;1;Pooled_heads
Candidate;Mvp;SB;216;1;21.63397598;1;Pooled_heads
Candidate;Mvp;PL;216;1;22.65891266;1;Pooled_heads
Candidate;Mvp;LB;216;1;21.62683868;1;Pooled_heads
Candidate;Mvp;AC;216;2;23.40564346;1;Pooled_heads
Candidate;Mvp;SB;216;2;21.86926651;1;Pooled_heads
Candidate;Mvp;PL;216;2;22.54525375;1;Pooled_heads
Candidate;Mvp;LB;216;2;21.84273911;1;Pooled_heads
Candidate;Jup;AC;178;1;21.92790604;1;Pooled_heads
Candidate;Jup;SB;178;1;21.33343506;1;Pooled_heads
Candidate;Jup;PL;178;1;21.1556282;1;Pooled_heads
Candidate;Jup;LB;178;1;21.10895157;1;Pooled_heads
Candidate;Jup;AC;178;2;22.24541092;1;Pooled_heads
Candidate;Jup;SB;178;2;21.60882187;1;Pooled_heads
Candidate;Jup;PL;178;2;21.35161018;1;Pooled_heads
Candidate;Jup;LB;178;2;21.14461136;1;Pooled_heads
Candidate;Jup;AC;216;1;22.64751434;1;Pooled_heads
Candidate;Jup;SB;216;1;20.92277527;1;Pooled_heads
Candidate;Jup;PL;216;1;21.7883091;1;Pooled_heads
Candidate;Jup;LB;216;1;21.11831665;1;Pooled_heads
Candidate;Jup;AC;216;2;22.39131927;1;Pooled_heads
Candidate;Jup;SB;216;2;21.19046783;1;Pooled_heads
Candidate;Jup;PL;216;2;21.52971077;1;Pooled_heads
Candidate;Jup;LB;216;2;21.01268768;1;Pooled_heads
Candidate;Lsr;AC;178;1;25.98275757;1;Pooled_heads
Candidate;Lsr;SB;178;1;24.9202652;1;Pooled_heads
Candidate;Lsr;PL;178;1;25.09762383;1;Pooled_heads
Candidate;Lsr;LB;178;1;24.9207077;1;Pooled_heads
Candidate;Lsr;AC;178;2;26.35001755;1;Pooled_heads
Candidate;Lsr;SB;178;2;25.15621948;1;Pooled_heads
Candidate;Lsr;PL;178;2;25.43023682;1;Pooled_heads
Candidate;Lsr;LB;178;2;24.90939903;1;Pooled_heads
Candidate;Lsr;AC;216;1;26.66849518;1;Pooled_heads
Candidate;Lsr;SB;216;1;24.91859436;1;Pooled_heads
Candidate;Lsr;PL;216;1;25.9844017;1;Pooled_heads
Candidate;Lsr;LB;216;1;24.82223892;1;Pooled_heads
Candidate;Lsr;AC;216;2;26.38882828;1;Pooled_heads
Candidate;Lsr;SB;216;2;24.8479538;1;Pooled_heads
Candidate;Lsr;PL;216;2;25.85172272;1;Pooled_heads
Candidate;Lsr;LB;216;2;24.95061493;1;Pooled_heads
Candidate;Rarg;AC;178;1;22.7040844;1;Pooled_heads
Candidate;Rarg;SB;178;1;23.38894272;1;Pooled_heads
Candidate;Rarg;PL;178;1;22.54174995;1;Pooled_heads
Candidate;Rarg;LB;178;1;22.86488724;1;Pooled_heads
Candidate;Rarg;AC;178;2;22.75419617;1;Pooled_heads
Candidate;Rarg;SB;178;2;23.29712677;1;Pooled_heads
Candidate;Rarg;PL;178;2;22.55051804;1;Pooled_heads
Candidate;Rarg;LB;178;2;22.38739395;1;Pooled_heads
Candidate;Rarg;AC;216;1;23.37831879;1;Pooled_heads
Candidate;Rarg;SB;216;1;22.82614708;1;Pooled_heads
Candidate;Rarg;PL;216;1;23.13128662;1;Pooled_heads
Candidate;Rarg;LB;216;1;22.88451385;1;Pooled_heads
Candidate;Rarg;AC;216;2;23.13782501;1;Pooled_heads
Candidate;Rarg;SB;216;2;22.66239929;1;Pooled_heads
Candidate;Rarg;PL;216;2;22.64619446;1;Pooled_heads
Candidate;Rarg;LB;216;2;22.82075882;1;Pooled_heads
Candidate;Vdra;AC;178;1;23.1421032;1;Pooled_heads
Candidate;Vdra;SB;178;1;23.39729309;1;Pooled_heads
Candidate;Vdra;PL;178;1;23.35404778;1;Pooled_heads
Candidate;Vdra;LB;178;1;22.97281265;1;Pooled_heads
Candidate;Vdra;AC;178;2;23.66833305;1;Pooled_heads
Candidate;Vdra;SB;178;2;22.62556458;1;Pooled_heads
Candidate;Vdra;PL;178;2;23.14506531;1;Pooled_heads
Candidate;Vdra;LB;178;2;23.04750061;1;Pooled_heads
Candidate;Vdra;AC;216;1;24.61454391;1;Pooled_heads
Candidate;Vdra;SB;216;1;23.10774994;1;Pooled_heads
Candidate;Vdra;PL;216;1;23.93480873;1;Pooled_heads
Candidate;Vdra;LB;216;1;23.15319443;1;Pooled_heads
Candidate;Vdra;AC;216;2;24.06957245;1;Pooled_heads
Candidate;Vdra;SB;216;2;23.00084305;1;Pooled_heads
Candidate;Vdra;PL;216;2;23.61406326;1;Pooled_heads
Candidate;Vdra;LB;216;2;23.3383255;1;Pooled_heads
Candidate;Tgfbr2;AC;178;1;25.73878098;1;Pooled_heads
Candidate;Tgfbr2;SB;178;1;25.08353806;1;Pooled_heads
Candidate;Tgfbr2;PL;178;1;24.9316082;1;Pooled_heads
Candidate;Tgfbr2;LB;178;1;24.94442558;1;Pooled_heads
Candidate;Tgfbr2;AC;178;2;26.16744232;1;Pooled_heads
Candidate;Tgfbr2;SB;178;2;24.9635582;1;Pooled_heads
Candidate;Tgfbr2;PL;178;2;25.13551331;1;Pooled_heads
Candidate;Tgfbr2;LB;178;2;25.28170395;1;Pooled_heads
Candidate;Tgfbr2;AC;216;1;26.54673386;1;Pooled_heads
Candidate;Tgfbr2;SB;216;1;25.25802994;1;Pooled_heads
Candidate;Tgfbr2;PL;216;1;25.86025238;1;Pooled_heads
Candidate;Tgfbr2;LB;216;1;25.04957581;1;Pooled_heads
Candidate;Tgfbr2;AC;216;2;26.1955204;1;Pooled_heads
Candidate;Tgfbr2;SB;216;2;25.22771835;1;Pooled_heads
Candidate;Tgfbr2;PL;216;2;25.63209915;1;Pooled_heads
Candidate;Tgfbr2;LB;216;2;25.05401039;1;Pooled_heads
Reference;If5a1;AC;200;1;23.47161865;2;Pooled_heads
Reference;If5a1;SB;200;1;23.07133942;2;Pooled_heads
Reference;If5a1;PL;200;1;24.18017319;2;Pooled_heads
Reference;If5a1;LB;200;1;23.15392525;2;Pooled_heads
Reference;If5a1;AC;200;2;22.9918045;2;Pooled_heads
Reference;If5a1;SB;200;2;22.64175262;2;Pooled_heads
Reference;If5a1;PL;200;2;24.18965607;2;Pooled_heads
Reference;If5a1;LB;200;2;22.71433945;2;Pooled_heads
Reference;Actb;AC;200;1;15.71403885;2;Pooled_heads
Reference;Actb;SB;200;1;15.22663116;2;Pooled_heads
Reference;Actb;PL;200;1;16.10777283;2;Pooled_heads
Reference;Actb;LB;200;1;15.57907486;2;Pooled_heads
Reference;Actb;AC;200;2;15.3622036;2;Pooled_heads
Reference;Actb;SB;200;2;14.8659539;2;Pooled_heads
Reference;Actb;PL;200;2;16.25887726;2;Pooled_heads
Reference;Actb;LB;200;2;15.21011208;2;Pooled_heads
Candidate;Mvp;AC;200;1;22.99713516;2;Pooled_heads
Candidate;Mvp;SB;200;1;21.39568901;2;Pooled_heads
Candidate;Mvp;PL;200;1;23.18587112;2;Pooled_heads
Candidate;Mvp;LB;200;1;21.54834557;2;Pooled_heads
Candidate;Mvp;AC;200;2;22.25123024;2;Pooled_heads
Candidate;Mvp;SB;200;2;21.20922089;2;Pooled_heads
Candidate;Mvp;PL;200;2;23.15605545;2;Pooled_heads
Candidate;Mvp;LB;200;2;21.26544952;2;Pooled_heads
Candidate;Jup;AC;200;1;21.87226295;2;Pooled_heads
Candidate;Jup;SB;200;1;20.7249527;2;Pooled_heads
Candidate;Jup;PL;200;1;22.22583961;2;Pooled_heads
Candidate;Jup;LB;200;1;20.83753967;2;Pooled_heads
Candidate;Jup;AC;200;2;21.48207474;2;Pooled_heads
Candidate;Jup;SB;200;2;20.41962051;2;Pooled_heads
Candidate;Jup;PL;200;2;22.50665092;2;Pooled_heads
Candidate;Jup;LB;200;2;20.57951736;2;Pooled_heads
Candidate;Lsr;AC;200;1;26.31171608;2;Pooled_heads
Candidate;Lsr;SB;200;1;24.93918991;2;Pooled_heads
Candidate;Lsr;PL;200;1;26.90993881;2;Pooled_heads
Candidate;Lsr;LB;200;1;24.93612099;2;Pooled_heads
Candidate;Lsr;AC;200;2;25.51472092;2;Pooled_heads
Candidate;Lsr;SB;200;2;24.41723633;2;Pooled_heads
Candidate;Lsr;PL;200;2;26.69015884;2;Pooled_heads
Candidate;Lsr;LB;200;2;24.50409126;2;Pooled_heads
Candidate;Rarg;AC;200;1;22.87320137;2;Pooled_heads
Candidate;Rarg;SB;200;1;22.46928978;2;Pooled_heads
Candidate;Rarg;PL;200;1;23.59035873;2;Pooled_heads
Candidate;Rarg;LB;200;1;22.55023003;2;Pooled_heads
Candidate;Rarg;AC;200;2;22.26335907;2;Pooled_heads
Candidate;Rarg;SB;200;2;21.93601608;2;Pooled_heads
Candidate;Rarg;PL;200;2;22.93943024;2;Pooled_heads
Candidate;Rarg;LB;200;2;22.08405304;2;Pooled_heads
Candidate;Vdra;AC;200;1;23.80267143;2;Pooled_heads
Candidate;Vdra;SB;200;1;22.66882515;2;Pooled_heads
Candidate;Vdra;PL;200;1;24.12267303;2;Pooled_heads
Candidate;Vdra;LB;200;1;22.74294662;2;Pooled_heads
Candidate;Vdra;AC;200;2;23.35219193;2;Pooled_heads
Candidate;Vdra;SB;200;2;22.05793114;2;Pooled_heads
Candidate;Vdra;PL;200;2;24.28331299;2;Pooled_heads
Candidate;Vdra;LB;200;2;22.67995148;2;Pooled_heads
Candidate;Tgfbr2;AC;200;1;25.97596741;2;Pooled_heads
Candidate;Tgfbr2;SB;200;1;25.18391418;2;Pooled_heads
Candidate;Tgfbr2;PL;200;1;26.6747036;2;Pooled_heads
Candidate;Tgfbr2;LB;200;1;24.9662075;2;Pooled_heads
Candidate;Tgfbr2;AC;200;2;25.64708328;2;Pooled_heads
Candidate;Tgfbr2;SB;200;2;24.92686844;2;Pooled_heads
Candidate;Tgfbr2;PL;200;2;26.92587662;2;Pooled_heads
Candidate;Tgfbr2;LB;200;2;24.89536095;2;Pooled_heads
Reference;If5a1;AC;178;1;23.35324097;3;Pooled_heads
Reference;If5a1;SB;178;1;23.25496864;3;Pooled_heads
Reference;If5a1;PL;178;1;23.09447479;3;Pooled_heads
Reference;If5a1;LB;178;1;22.99862671;3;Pooled_heads
Reference;If5a1;AC;178;2;23.20590973;3;Pooled_heads
Reference;If5a1;SB;178;2;23.23107544;3;Pooled_heads
Reference;If5a1;PL;178;2;23.07160378;3;Pooled_heads
This is a portion of the data; to view all the data, please download the file.
Dataset 3.qPCR data for tests of expression in charr developing embryo heads.
“Gene Type”: Designates the reference and candidate genes. “Gene”: Name of the gene. “Morph”: Which charr type the sample came from. “Relative age”: Developmental timepoint. “Biological replicate”: The two or more biological replicates used. “cDNA No”: Marks the cDNA isolation used. “Ct value”: Estimate of gene expression. “Tissue”: Indicates the material used112.

Discussion

We are interested in how predictable evolution is a the molecular level and if there certain principles influence the rewiring of developmental and regulatory systems during evolution81. One way to study this is to identify genetic and developmental effects affecting key traits in species or populations which exhibit parallel evolution. The objective of this study were to get a handle on genetic and molecular systems that associate with benthic morphology in charr by mainly focusing on the small benthic morph in Lake Thingvallavatn, Iceland. To this end we performed transcriptome analysis contrasting the development of embryos from SB-charr and aquaculture charr.

Developmental transcriptome of Arctic charr morphs

As no reference genome is available for Arctic charr, we mapped reads to S. salar EST-contigs63 in order to estimate expression and identify candidate genetic polymorphisms. As many of the contigs are short or have overlapping annotations, we collapsed genes into paralogous genes when appropriate for the expression analysis. The main advantage of this approach was the reduction of the number of statistical tests (and hence an increase in statistical power). The downside is that paralog-specific expression patterns are masked, as our qPCR results of the natterin like gene family show (Figure 3 and S1 Figure). Recent rainbow trout data shows most paralogs from the latest whole genome duplication event retain the same expression pattern32 indicating that this scenario is probably uncommon; hence it is of considerable interest when two paralogs show distinct expression patterns82. In their analysis of the Arctic charr gill transcriptome, Norman et al. (2014)16 also used Illumina sequencing technology to evaluate expression. Their reads were longer (2x100 bp) than in this study (36 bp) enabling them to assemble contigs. They did not consider the paralogs in their approach and merged contigs based on sequence identity. Thus the complexity of Arctic charr transcriptome still remains a mystery that advances in sequencing technology, assembly algorithms and genome sequencing of this species could aid in revealing.

Our data reflects differential deployment of several gene classes during Arctic charr development. Studies in salmonids and other fish have demonstrated large changes in expression during early development, including coordinated changes in many cellular and developmental systems12,19,8385. Several blood coagulation factors genes showed significant changes during charr development, and were also more highly expressed in the SB-charr. This might reflect differences in the rate of development of blood composition, or tissue composition, in the two morphs. Our main interest is on the derived and repeatedly evolved small benthic charr. For this study we chose AC-charr as a point of reference for several reasons, i) it has limnetic like head morphology, ii) availability, and iii) because we wanted a strong contrast in this first survey of charr developmental diversity. The AC-charr proved a useful, as the data presented here has already revealed differential expression of several developmental genes and regulators with differential expression between benthic and limnetic charr58,59. Furthermore we previously found tight correlation of RNA-seq expression and qPCR estimates - in this very same transcriptome58. Furthermore, we have actually used the same morphs (AC and SB) and samples in a comparison of the developmental miRNA transcriptome – which reveal that expression of several miRNAs correlates with morph differences62.

Higher expression of lyzozyme and natterin-like in SB-charr

The genetic separation in two immunity genes among sympatric morphs in Lake Thingvallavatn52 prompted us to examine further the expression of Lyz and nattl that were differentially expressed between morphs.

Both genes are expected to be involved in immune defenses and had higher expression in SB. The substrate of lysozyme86 is the bacterial cell wall peptidogly-can and it acts directly on Gram-positive bacteria87. Lysozyme also promotes the degradation of the outer membrane and therefore indirectly acts also on Gram-negative bacteria88. Another gene that caught our attention was natterin-like. Natterins were first discovered from the venom gland of the tropical toxic fish species Thalassophryne nattereri75,76, and are found by sequence similarity in e.g. zebrafish, Atlantic salmon and here in Arctic charr. The predicted Natterin proteins contain a mannose-binding lectin-like domain (Jacalin-domain) and a pore-forming toxin-like domain and can cause edema and pain due to kininogenase activity75. Mannose-binding lectins are pathogen recognition proteins (antibodies) and therefore are important for the acute phase response of fish89,90. Our data suggest an immune related function of nattl genes in charr, as the highest expression was found in skin and kidney. This needs to be verified. It is possible that higher expression of those two genes in SB-charr reflect preparation of juveniles for bottom dwelling habitats, which may be rich in bacteria and challenging for immune systems.

In this study we collapsed contigs into gene or paralog groups for the transcriptome analyses. The disadvantage of this approach is that differential expression in one paralog, can be masked by other related genes that do not differ between groups or have contrasting expression patterns. We looked at this by studying the expression of three paralogs of the natterin like genes in different morphs during Arctic charr development, and among tissues of adult AC-charr. The data show that the three nattl genes are expressed differentially between the morphs, thus it is not divergence in the expression of one paralog that explains the general nattl expression disparity in the transcriptome. Certainly, other scenarios could apply to other genes in the transcriptome.

Expression divergence in craniofacial genes in benthic morphs

A study of the skulls of charr post-hatching embryos and juveniles from Lake Thingvallavatn, showed that some elements of the developing head ossified earlier in SB-charr than in PL-charr91. Our new data also demonstrate differences in craniofacial elements between AC- and SB-charr, along a limnetic vs. benthic axis79. Based on those differences between benthic and limnetic charr, we investigated further genes with roles in craniofacial development that were differentially expressed in the transcriptome. Guided by this transcriptome we had already found two extra-cellular matrix (ECM) remodeling genes, Mmp2 and Sparc and a conserved co-expression module of genes with known roles in craniofacial morphogenesis, to have higher expression in developing heads of benthic Arctic charr morphs than in limnetic morphs58,59. Bioinformatic and qPCR analyses suggest the co-expression module may potentially be affected by quantity of the transcription factor ETS2. These studies and the current data confirm the utility of the contrasting developmental transcriptomes for identifying candidate genes with differential expression during head development, as 7 out of 8 candidates were confirmed by qPCR. These genes had consistently higher expression in the developing head of two benthic morphs (SB and LB), and lower in more limnetic fish (AC and PL). This is striking, as three of the morphs (SB, LB and PL) studied are closely related and live in sympatry in Lake Thingvallavatn52.

We focused on a few targets of Tgf-β and Ahr signaling pathways because of their role in craniofacial morphogenesis and transcriptional connection9294. Adseverin (Scin) was one of the top differentially expressed genes (Table 1) and has roles in rearrangements of the actin cytoskeleton, chondrocyte differentiation and skeletal formation95,96. Also, in the transcriptome Lsr, Cldn4 and Tgfbr2 had higher expression in SB-charr, and we show that higher expression of those genes associated with the benthic morphotype. Lsr is a molecular component of tri-cellular tight junctions97 and has been shown to be suppressed upon Tgf-β1 stimulation98 in a human cell line. Similarly, Cldn4, a tight junction protein with unknown role during embryonic morphogenesis, is a target of the Tgf-β and Ahr signaling pathways99,100. Finally, the expression of Tgfbr2, encoding a receptor of Tgf-β was slightly but significantly higher in the head of benthic morphs. Previous studies suggest a crucial role of Tgfbr2 in craniofacial morphogenesis101.

We also confirmed differential expression of other genes, including two with higher expression in SB-charr. Mvp is the predominant component of cytoplasmic ribonucleoprotein structures called vaults102, which is highly conserved across eukaryotes. The vaults have been something of an enigma, but are implicated in several processes from signal transmission and immune response103. The Jup gene also showed higher expression in SB-charr. Finally, higher expression of Vdra, encoding the vitamin D receptor A, was found in the heads of benthic forms. The receptor regulates mineral homeostasis, osteoblast differentiation and bone metabolism104.

To summarize, the results show that RNA-sequencing of Aquaculture charr with limnetic craniofacial morphology and small benthic charr can be used to reveal differential expression of genes that associate with limnetic and benthic divergence in craniofacial elements in sympatric charr morphs. It would be interesting if expression of these genes associates with benthic morphology in independently evolved charr populations, or even in other species with similar trophic diversity.

mtDNA function divergence in Arctic charr?

By comparing AC and SB-charr, that represents a small benthic resource morph that has evolved repeatedly in Icelandic stream and pond habitats51, we hoped to implicate genes and pathways involved in adaptation to these special habitats. The data point to differences between SB and AC-charr in systems related to energy metabolism, as may be expected considering their contrasting life histories. First, there is 2X higher expression of respiratory electron transport chain components in AC compared to SB-charr and 100% more mitochondrial derived reads are found in the AC-charr samples. Note that the direction of divergence is unknown, i.e. whether expression was up in AC or down in SB. Second, many derived candidate-SNPs in genes related to mitochondrial function were at high frequency on the AC branch. For instance in S100A1, which has been implicated in mitochondrial regulation in cardiac tissue in humans105, but its expression is probably not exclusive to this tissue. Third, while the mitochondrial ribosomal genes generally evolve slowly, we do see derived variants at high frequency in the SB and large benthic charr in Lake Thingvallavatn. Specifically, m3411C>T in SB affects a position that is highly conserved among fish, and could affect function of the 16s rRNA. Earlier studies of mitochondrial markers in S. alpinus did not find large signals of divergence within Iceland47,49,52, probably because they studied other genes. In summary, the results suggest divergence in mitochondrial function, due to the domestication of aquaculture charr and/or possibly reflecting adaptation of the small benthic charr in Lake Thingvallavatn.

The mitochondrion is more than a powerhouse, it integrates metabolism, cell cycle and apoptosis106. The number of mitochondria and its functions are known to correlate with environmental attributes. For instance in Antarctic fishes under extreme cold, higher numbers of mitochondria are found in muscle and heart cells107. Our data suggest an expression difference between morphs that could reflect differences in total number of mitochondrion, the number of mtDNA copies per mitochondrion or cell, or difference in RNA expression from the mtDNA, possibly due to evolution of mtDNA related to diet and/or temperature108. Further work is needed to map out the expression differences of mitochondrial related genes in more SB and anadromous charr morphs (representing the ancestral state). The mtDNA signals could also be investigated in populations along ecological clines (e.g. temperature) or with respect to life history109.

Conclusions

The data presented here set the stage for future investigations of the molecular and genetic systems involved in the development and divergence of the highly polymorphic and rapidly evolving Arctic charr. The results suggest genetic and expression changes in multiple systems relate to divergence among populations. The data reveal differential expression of two immunological genes between morphs and of several craniofacial developmental genes, that may help sculpture benthic vs. limnetic heads. The genetic data suggest among other things differentiation in the charr mtDNA between morphs. Our broad interest is in how natural selection tweaks genetic regulatory systems, for instance via genetic changes in regulatory sequences or post transcriptional modifiers relating to adaptations. Genetic changes affecting gene expression can be raw material for adaptation, but could also rise in frequency due to reverberations in regulatory cascades81. Our specific aim was to cast light on the developmental and population genetics of the unique small benthic charr, typically found in cold springs and small pond habitats in Iceland, particularly those with lava substratum36,51. The availability of charr populations at different stages of divergence sets the stage for future genomic studies of the roles of genes, environment and plasticity for shaping this polymorphic species.

Data availability

F1000Research: Dataset 1. Parameters and multiple testing corrected p-values for expression analysis, 10.5256/f1000research.6402.d48005110

F1000Research: Dataset 2. qPCR data for tests of expression in charr developing embryos and adult tissues., 10.5256/f1000research.6402.d48006111

F1000Research: Dataset 3. qPCR data for tests of expression in charr developing embryo heads., 10.5256/f1000research.6402.d48007112

Comments on this article Comments (0)

Version 3
VERSION 3 PUBLISHED 01 Jun 2015
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Gudbrandsson J, Ahi EP, Franzdottir SR et al. The developmental transcriptome of contrasting Arctic charr (Salvelinus alpinus) morphs [version 1; peer review: 2 approved with reservations]. F1000Research 2015, 4:136 (https://doi.org/10.12688/f1000research.6402.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 01 Jun 2015
Views
46
Cite
Reviewer Report 09 Jul 2015
Anne Dalziel, Institute for Systems and Integrative Biology (IBIS), Department of Biology, Laval University, Quebec City, QC, Canada 
Approved with Reservations
VIEWS 46
In this paper “The developmental transcriptome of contrasting Arctic charr (Salvelinus alpinus) morphs” Gudbrandsson et al. have tested for differential gene expression at multiple developmental time-points among a number of Artic charr morpho-types from Lake Thingvallavatn (3 wild morphs, 1 ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Dalziel A. Reviewer Report For: The developmental transcriptome of contrasting Arctic charr (Salvelinus alpinus) morphs [version 1; peer review: 2 approved with reservations]. F1000Research 2015, 4:136 (https://doi.org/10.5256/f1000research.6869.r9419)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 25 Apr 2016
    Arnar Palsson, Institute of Life and Environmental Sciences, University of Iceland, Reykjavik, 101, Iceland
    25 Apr 2016
    Author Response
    Major Comments

        Introduction:‭

    ‬Requires some reorganization,‭ ‬clarification of what phenotypes have evolved in parallel among morphs,‭ ‬and how the authors separate the effects of domestication‭ (‬SB vs.‭ ‬AC‭) ‬from benthic/limnetic evolution‭
    ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 25 Apr 2016
    Arnar Palsson, Institute of Life and Environmental Sciences, University of Iceland, Reykjavik, 101, Iceland
    25 Apr 2016
    Author Response
    Major Comments

        Introduction:‭

    ‬Requires some reorganization,‭ ‬clarification of what phenotypes have evolved in parallel among morphs,‭ ‬and how the authors separate the effects of domestication‭ (‬SB vs.‭ ‬AC‭) ‬from benthic/limnetic evolution‭
    ... Continue reading
Views
66
Cite
Reviewer Report 07 Jul 2015
Daniel Macqueen, Institute of Biological and Environmental Sciences, University of Aberdeen, Aberdeen, UK 
Approved with Reservations
VIEWS 66
Review of Gudbrandsson et al. “The developmental transcriptome of contrasting Arctic charr (Salvelinus alpinus) morphs”.

The work is founded on the solid premise that rapidly evolving phenotypes in nature can be underpinned by changes at the transcriptome level. The model system ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Macqueen D. Reviewer Report For: The developmental transcriptome of contrasting Arctic charr (Salvelinus alpinus) morphs [version 1; peer review: 2 approved with reservations]. F1000Research 2015, 4:136 (https://doi.org/10.5256/f1000research.6869.r8970)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 25 Apr 2016
    Arnar Palsson, Institute of Life and Environmental Sciences, University of Iceland, Reykjavik, 101, Iceland
    25 Apr 2016
    Author Response
    Main comments‭ & ‬caveats

        RNAseq study design.‭ ‬ I sympathize with the fact that the authors are trying to publish Illumina data that was generated in‭ ‬2009,‭ ‬since‭ (‬obviously‭) ‬the technology
    ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 25 Apr 2016
    Arnar Palsson, Institute of Life and Environmental Sciences, University of Iceland, Reykjavik, 101, Iceland
    25 Apr 2016
    Author Response
    Main comments‭ & ‬caveats

        RNAseq study design.‭ ‬ I sympathize with the fact that the authors are trying to publish Illumina data that was generated in‭ ‬2009,‭ ‬since‭ (‬obviously‭) ‬the technology
    ... Continue reading

Comments on this article Comments (0)

Version 3
VERSION 3 PUBLISHED 01 Jun 2015
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.